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Abstract
Assessment of the progression of the tumors in current clinical practice is based
on maximum diameter measurements, which are related to the volumetric changes.
With the advent of the spatially localized radiotherapy techniques (i.e. Cyberknife,
IMRT, Gammaknife, Tomotherapy) not only the volumes of the tumors but also
the geometric changes need to be considered to measure the effectiveness and to
improve the applied therapy.
In this thesis, image analysis techniques are developed for assessment of the
changes of the tumor geometry between MRI volumes acquired after and before
the therapy. Three main parts of the thesis are: Segmentation of brain tumors on
MRI; change quantification in temporal MRI series of brain tumors; and deformable
registration of brain MRI volumes with tumors.
The results obtained by the developed semi-automatic brain tumor segmentation
method, Tumor-cut, are comparable with those of state-of-the-art techniques in the
field. The quantification of tumor evolution using the invariants of the Lagrange
strain tensor provide measures that are more correlated with the clinical outcome
than the volumetric measures. The deformable registration of longitudinal data
provides a novel framework to study brain deformations, in vivo, and more accurate
assessment of the changes.
BEYI˙N TU¨MO¨RU¨ TEDAVI˙ TAKI˙BI˙ I˙C¸I˙N GO¨RU¨NTU¨ ANALI˙ZI˙ YO¨NTEMLERI˙
Andac¸ Hamamcı
EE, Doktora Tezi, 2013
Tez Danıs¸manı: Go¨zde U¨NAL
Anahtar Kelimeler: Beyin tu¨mo¨ru¨, Radyocerrahi, Radyoterapi, C¸akıs¸tırma,
Bo¨lu¨tleme, MR deg˘is¸im takibi, Tu¨mo¨r itme etkisi
O¨zet
Gu¨nu¨mu¨z klinik uygulamalarında, tu¨mo¨rlu¨ dokuların takibi, hacim deg˘is¸imini yansıtan
c¸ap o¨lc¸u¨mleriyle yapılmaktadır. Ancak, IMRT, CyberKnife, GammaKnife, To-
moterapi gibi lokalize radyoterapi tekniklerinin gelis¸imine paralel olarak, uygulanan
terapinin bas¸arısının deg˘erlendirilmesi ve gelis¸tirilmesi ic¸in lokal geometrik deg˘is¸imlerin
de deg˘erlendirilmesine ihtiyac¸ duyulmaktadır.
Bu tezde, terapi o¨ncesi ve sonrasında alınan MR hacimleri arasında tumor ge-
ometrisindeki deg˘is¸imlerin deg˘erlendirilmesine yo¨nelik go¨ru¨ntu¨ analizi teknikleri gelis¸tirilmis¸tir.
Tez u¨c¸ ana parc¸adan olus¸maktadır: Beyin tu¨mo¨rlerinin MR go¨ru¨ntu¨lerinde bo¨lu¨tlenmesi;
MR serilerinde tu¨mo¨r deg˘is¸iminin kuantifikasyonu; tu¨mo¨rlu¨ beyin MR go¨ru¨ntu¨lerinin
c¸akıs¸tırılması.
Gelis¸tirilen yarı-otomatik beyin tu¨mo¨ru¨ bo¨lu¨tleme yo¨ntemi literatu¨rdeki en bas¸arılı
tekniklere benzer sonuc¸lar sag˘lamaktadır. Tu¨mo¨r deg˘is¸iminin Lagrange gerilme
tenso¨ru¨ deg˘is¸mezleri kullanılarak elde edilen o¨lc¸u¨tlerle deg˘erlendirmesi, hacim o¨lc¸u¨tlerine
kıyasla, klinik sonuc¸larla daha iyi o¨rtu¨s¸en sonuc¸lar sag˘lamaktadır. Farklı zaman-
larda alınan MR go¨ru¨ntu¨lerinin bic¸imlenebilir c¸akıs¸tırması beyin deformasyonlarının
canlı dokuda incelenmesini sag˘layan bir c¸erc¸eve sunmakta ve deg˘is¸imlerin daha has-
sas bir s¸ekilde deg˘erlendirilmesini sag˘lamaktadır.
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Chapter 1
Introduction
1.1 Brain Tumors
Brain tumors are a set of neoplasms, which are caused by uncontrolled cell pro-
liferation, and do not necessarily arise from brain tissue (e.g., meningiomas and
lymphomas) [3, 4]. World Health Organization (WHO) classification of Central
Nervous System (CNS) tumors is based on the identification of different histopatho-
logic groups and includes a scale of malignancy, ranging from grade I benign forms
to grade IV forms with rapid growth and poor prognosis [5].
Approximately 40% of intracranial neoplasms are metastatic, which originate
most frequently from lung, breast, melanoma, renal and colon cancers, whereas
remaining are primary brain tumors. Gliomas are the most frequent primary brain
tumors in adults and account for 70% of adult malignant primary brain tumors [4].
Nearly 50% of the gliomas are WHO grade IV tumors, which are called glioblastoma
multiforme (GBM), exhibiting very rapid growth, with an average survival time of
one year. Meningiomas, which arise from meningothelial cells that form the external
membranous covering of the brain, are the most common extra-axial intracranial
neoplasms, which account for 15-20% of intracranial neoplasms [3, 4].
The symptoms of a brain tumor depend mainly on its location and its size and
consequently on the function of areas involved by the tumor, with a variety of
nonspecific symptoms typical of a mass growing inside the skull with increased in-
tracranial pressure. Common symptoms are persistent headache, nausea, vomiting
(usually morning), disorders of retina like papilledema caused by the dilatation of
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cerebral vessels, focal deficit (hemiparesis, hemianesthesia, hemianopsia, diplopia,
aphasia) and seizures due to tumor irritation effect (present up to one third of pa-
tients); moreover nonspecific neurologic symptoms such as clouding of consciousness
and personality changes [6].
Ionizing radiation is the only unequivocal risk factor that has been identified
for glial and meningeal neoplasms. Irradiation of the cranium, even at low doses,
can increase the incidence of meningiomas by a factor of 10 and the incidence of
glial tumors by a factor of 3 to 7 with a latency period of 10 years to more than 20
years after exposure. No other environmental exposure or behavior has been clearly
identified as a risk factor. The use of cellular telephones, exposure to high-tension
wires, the use of hair dyes, head trauma, and dietary exposure to N-nitro sourea
compounds or other nutritional factors have all been reported to increase the risk
of brain tumors; however, the data are conflicting and unconvincing [3].
The treatment of brain tumors is complex and depends on several factors such
as histologic type, location and extension, age and general conditions of the patient.
Brain tumors can be treated with surgery, radiation therapy (RT) and chemotherapy,
often in combination, in relation to the needs of patient [7].
1.2 MR Imaging of the Brain Tumors
Although computed tomography (CT) is also used to diagnose the brain tumors,
it can miss structural lesions such as nonenhancing tumors. Therefore, if a brain
tumor is a diagnostic consideration, MRI with gadolinium enhancement is the test
of choice [3].
MRI makes it possible to produce markedly different types of tissue contrast
by varying excitation and repetition times, which makes it a very versatile tool for
imaging different structures of interest. In current clinical routine, different MRI
sequences are employed for the diagnosis and delineation of tumor compartments
[4]. The brain tumor MR protocol, with and without contrast agent administration
should include T2-weighted and T2-weighted fluid-attenuated inversion recovery
(T2-FLAIR) sequences, best performed in 3D, generally in axial or coronal views,
and T1-weighted sequences with and without contrast enhancement [6].
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In MR imaging of glioblastoma, the solid part of the tumor shows hypointense
signal in T1-weighted sequences and hyperintense in T2, with higher signal in areas
of greater cellularity. Necrotic areas, which always appear hyperintense in T2, may
be hypo-, iso- or hyperintense in T1 due to products of protein or hemoglobin degra-
dation. Enhancement after administration of contrast medium is usually intense and
irregular at the tumor margins and identifies the cellular proliferation component of
the tumor. Punctate and serpiginous areas of no signal caused by flow associated
with neovascularization are common. These newly formed pathologic vessels are de-
void of blood-brain barrier (BBB), which explains both their marked enhancement
and perilesional vasogenic edema, due to the passage of fluid in the extracellular
space [6].
1.3 Current Medical Practice and Clinical Moti-
vation
1.3.1 Radiotherapy Treatment
Radiation therapy (RT) is a nonsurgical treatment that uses radiation to eradicate
tumor or to restrict its growth. For some cancer types particularly sensitive to
radiation, RT often in combination with chemotherapy may be the only therapeutic
approach required. In other cases, RT is used in combination with surgery to remove
any residual tumor not removed during surgery. RT can also be used in nonoperable
tumors to reduce metastatic spread or relieve symptoms.
Radiation can kill cells or block their ability to proliferate. Although, they act
both on tumor cells and normal cells, tumor cells are more sensitive to radiation
due to high proliferation rate, so it is possible to protect healthy cells by applying
the dose as fractions (i.e. Intensity Modulated Radiotherapy). On the other hand,
stereotactic radiosurgery (SRS) consists in the administration of highly collimated
beams of radiation through multiple non-coplanar arcs that intersect at a single point
(i.e. Cyber-knife, Gamma-knife etc.). This method involves the administration
of the entire dose in a single session with a rapid fall of the dose to surrounding
tissue. Stereotactic radiosurgery is feasible for small unifocal tumors (up to 4 cm),
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metastases, tumors which are unreachable by surgery or recurrence especially in
patients already receiving the maximum tolerable radiation dose.
Generally brain cells are very resistant to irradiation, while other cell types (bone
marrow cells, germinal cells, epithelium lining hollow organs) are very sensitive,
which is why the approach is to restrict the radiotherapeutic target volume as much
as possible [6]. Advanced radiotherapeutic devices allow the delivery of a high dose
to a precisely defined target volume, whereas keeping the dose on normal tissue at
minimum. Diagnostic imaging with CT and MR is essential for defining the target
volume and planning treatment. MRI is used to define the target volume, which
is the pathologic tissue irradiated with high dose, and organs at risk, which are
protected from the high dose radiation. Planning CT scan is still necessary for it
provides the attenuation coefficient map and serves as a reference for registration
during the therapy.
In planning radiotherapy treatment of brain tumors, first, the MR images ac-
quired with different sequences are registered to the contrast enhanced T1 images.
Then each MR image is transformed to CT space by applying the transformation
obtained by registering contrast enhanced T1 image to the CT image. The target
volumes and organs at risk (OAR) are contoured manually or interactively on MRI
using computer tools. In radiotherapy, the planning target volume (PTV) is defined
in 3 stages: The gross tumor volume (GTV) is defined as the surgical cavity and
any residual diseased tissue visualized with contrast enhancement in T1-weighted
images of postoperative MR; the clinical target volume (CTV) is defined as GTV
plus an expansion margin of 2 cm where there may be infiltration of tumor cells; the
PTV is represented by CTV plus an expansion margin of 1 cm [6]. The treatment
plan is determined on the CT image depending on the type of the therapy and tu-
mor; and controlled by optical tracking or registering x-ray scans acquired during
treatment. A similar procedure is applied in radiosurgery (i.e. CyberKnife), except
with a more conservative and precise definition of the target volume (PTV=GTV),
due to its less differentiation of tumor/healthy cells.
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1.3.2 Image Analysis for the Radiotherapy Treatment
As described above, advanced image analysis techniques are involved in different
stages of the radiotherapy treatment of brain tumors. Rigid/affine registration of
multi-modal MR images to CT images, having different contrast characteristics, is
performed. Rigid/affine registration using normalized cross correlation or mutual
information based algorithms are quite mature and are applied confidently to the
problem. Segmentation of the gross tumor volume (GTV), surrounding edema and
necrosis within GTV, is a widely studied problem in the literature, which aims to
reduce the intra-observer variability and workload in treatment planning.
Full-automatic tumor segmentation methods, commonly based on machine learn-
ing [8], require large training samples, and may miss “unlearned” heterogeneous
structures. They also do not use the information provided by the radiological ex-
amination, e.g. the volume of interest (VOI) and sampling from the tumor tis-
sue through line diameter measurements. Semi-automatic methods are more user-
friendly and appropriate to the clinical workflow, where the clinician wants to inter-
act with the segmentation process. The challenge in MR tumor segmentation is to
develop highly accurate and precise algorithms which are robust to highly heteroge-
neous tumor characteristics. In this thesis, the brain tumor segmentation problem,
which is a part of the planning stages of radiotherapy as well as radiosurgery, is
addressed, both in a mono-modal and a multi-modal setting.
1.3.3 Tumor Follow-up
The advent of MRI scanning protocols has allowed accurate follow-up of tumor
growth through volumetric measurements. Interpretation of the radiological evolu-
tion of the tumor appears of utmost importance for therapeutic management, es-
pecially for low-grade glioma. Indeed, patients are most of the time asymptomatic
(except in the case of epilepsy) during the low-grade phase, and the tumoral evolu-
tion is only monitored by MRI follow-up, both prior and after treatment. However,
such information about the tumor dynamics is usually not fully integrated with the
therapeutic strategy, and the assessment of the tumor evolution is still limited to
qualitative descriptions (recurrence, progression, regression, stability)[9].
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The neuroradiologic follow-up protocol in treated patients usually includes the
following MR examinations:
• within 2-3 days after surgery to evaluate the radicality of surgery;
• 30 days after surgery (often the first follow-up examination);
• 30 days after completing treatment;
• every 3 months (high-grade gliomas) and every 6 months (low-grade gliomas)
to evaluate tumor growth.
After treatment, it is necessary to wait some time before evaluating the results of
RT: during this period, in fact, tumor cells damaged during the course of treatment
undergo apoptosis. Often this process produces a degree of edema which can cause
symptoms similar to cancer and which in radiologic imaging can simulate tumor
growth [6].
In tumor follow-up studies, the most widely used criteria for assessing response
to therapy in high-grade gliomas are based on two-dimensional tumor measurements
which is the product of the maximal cross-sectional enhancing diameters (the Mac-
donald Criteria) [10, 11]. Currently, one-dimensional tumor measurements, which
were first introduced in “The Response Evaluation Criteria in Solid Tumors” (RE-
CIST), have become the standard criteria to determine response. The Response
Assessment in Neuro-Oncology Working Group (RANO), an international effort to
develop new standardized response criteria for clinical trials in brain tumors, con-
siders also the non-enhancing tumors [12].
Limitations of two dimensional measurements include the difficulty of measur-
ing irregularly shaped tumors, interobserver variability, the lack of assessment of
the nonenhancing component of the tumor, lack of guidance for the assessment of
multifocal tumors, and the difficulty in measuring enhancing lesions in the wall of
cystic or surgical cavities because the cyst/cavity itself may be included in the tu-
mor measurement. Given the limitations of two-dimensional tumor measurements,
there is significant interest in volumetric anatomic assessment. The use of volumet-
ric assessment would allow more accurate determination of the contrast-enhancing
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and nonenhancing volumes and overcome the limitations of two-dimensional mea-
surements of lesions surrounding a surgical cavity [12].
Furthermore, with the advent of the spatially localized radiotherapy techniques
(i.e. Cyberknife, IMRT, Gammaknife, Tomotherapy) not only the volumes of the
tumors but also the geometric changes need to be considered to measure the effec-
tiveness and to improve the applied therapy.
An accurate determination of the actual tumor evolution requires full 3D seg-
mentation on digital images. Manual segmentation by an expert is still consid-
ered as the reference method, but is a time consuming task with high inter and
intra-observer variability[9]. Konukoglu et. al. suggested a registration method for
monitoring slowly evolving meningiomas, which performed semiautomatic tumor
segmentation, non-rigid registration and change detection consecutively [13]. They
argued that their volume-change measurements were less user-biased than manual
measurements.
1.3.4 Image Analysis for the Tumor Follow-up
Computational methods used in tumor follow-up usually involve registration, seg-
mentation and change quantification steps. Three different image registration prob-
lems arise as: intra-patient multi-modal registration at a time; longitudinal registra-
tion of images; inter-patient spatial normalization of brain tumor images to a brain
atlas. Spatial normalization is commonly used for atlas-based segmentation [14] or
constructing statistical tumor atlases [15, 16]. Intra-patient multi-modal MR regis-
tration is a common problem and can be solved successfully by a rigid registration
algorithm using mutual information based similarity measure. However, for the lon-
gitudinal registration problem, not only the change of the appearance of the tumor
in time, but also the deformation of the surrounding healthy tissue due to the mass
effect of the tumor should be considered. This would require a deformable registra-
tion of the volumes to obtain a proper correspondence. Although, the inter-patient
spatial normalization of tumor images also requires a deformable registration to be
employed, the deformation in this case is not only due to the well defined mechanical
effects but also includes interpersonal anatomical variability. Furthermore, the pres-
ence of a tumor in images represents a challenge for atlas registration algorithms:
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the assumption of an intensity relationship between homologous structures does not
hold, as the presence of a tumor in the image changes the MR signal in invaded
areas. The initial approach to tackle this problem consisted in discarding the tu-
mor region from the similarity criteria [17]. Another more sophisticated approach
employs tumor growth simulations to generate a similar tumor on the atlas image
[15, 18].
The problem of segmentation of the tumors on multi-modal MR images is similar
to radiotherapy planning as described in 1.3.2. Another open problem in follow-up
is the quantification and visualization of the changes, locally. The challenge here is
both to understand the clinical needs and develop mathematical techniques to meet
those requirements.
1.4 Thesis contributions and Overview
In this thesis, image analysis techniques are developed for treatment planning and
assessment of the changes of the tumor geometry between MRI volumes acquired
after and before the therapy. Three main parts of the thesis are: Segmentation of
brain tumors on MRI, deformable registration of brain MRI volumes with tumors,
and change quantification in temporal MRI series of brain tumors. The outline of
the thesis is as following:
In this Introduction chapter, current medical practice of radiotherapy treatment
and follow-up of brain tumors; and related image analysis methods are summarized
in general.
In Chapter 2, a novel semi-automatic method, namely “Tumor-cut”, to seg-
ment the core of the brain tumors on contrast enhanced T1-weighted MR images by
evolving a level-set surface on a probability map obtained using cellular automata
algorithm is presented. The Cellular Automata (CA) algorithm is re-examined to
establish the connection of the CA-based segmentation to the graph-theoretic meth-
ods to show that the iterative CA framework solves the shortest path problem with
a proper choice of the transition rule. The performance is evaluated qualitatively
and quantitatively on synthetic and clinical datasets. This chapter appeared as a
journal article in IEEE Transactions on Medical Imaging, 31(3), pp.790-804, 2012.
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In Chapter 3, the ”Tumor-cut” method is extended to process multi modality
MR images. The performance of the algorithm is evaluated on BraTS multi-modal
brain tumor dataset available online. The results obtained are compared to the state-
of-the-art techniques participated in the BraTS challenge. The work presented in
this chapter appeared in Proceedings of MICCAI-BRATS 2012 October 1st, Nice,
France and is in preparation for joint paper submission.
In Chapter 4, local tumor response criteria to quantify the change of the tumor
are proposed based on the invariants of the Lagrange strain tensor. The value of
the proposed technique is evaluated on synthetically created phantoms and clinical
MR cases, compared to the volumetric changes and the radiological assessments.
The work presented in this chapter appeared in the European Society of Magnetic
Resonance in Medicine and Biology (ESMRMB) Conference, 2012.
A novel method for deformable registration of intra-patient longitudinal MR
volumes, using hyper-elastic brain deformation models, is presented in Chapter 5.
Preliminary part of this work presented in this chapter appeared in the Compu-
tational Biomechanics for Medicine, pp. 101-114, Springer, 2013 and the current
version is in preparation for submission as a journal article.
The thesis is summarized in the last chapter and the methods developed are
discussed, providing the possible future directions.
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Chapter 2
Tumor-Cut: Segmentation of
Brain Tumors on Contrast
Enhanced MR Images for
Radiosurgery Applications 1
2.1 Introduction
Segmentation of brain tissues in gray matter[19], white matter[20], and tumor[21]
on medical images is not only of high interest in serial treatment monitoring of “dis-
ease burden” in oncologic imaging, but also gaining popularity with the advance of
image guided surgical approaches. Outlining the brain tumor contour is a major
step in planning spatially localized radiotherapy (e.g. Cyberknife, iMRT) which
is usually done manually on contrast enhanced T1-weighted Magnetic Resonance
Images (MRI) in current clinical practice. On T1 MR images acquired after ad-
ministration of a contrast agent (gadolinium), blood vessels and parts of the tumor,
where the contrast can pass the blood-brain barrier are observed as hyper intense
areas. There are various attempts for brain tumor segmentation in the literature
which use a single modality, combine multi modalities and use priors obtained from
population atlases [9].
1This chapter appeared as a journal article in IEEE Transactions on Medical Imaging, 31(3),
pp.790-804, 2012.
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Modalities which give relevant information on tumor and edema/infiltration such
as Perfusion Imaging, Diffusion Imaging or Spectroscopic Imaging provide lower
resolution images compared to T1 or T2 weighted sequences, and the former are
generally not preferable for geometric measurements. One of the main reasons to
use multi-modality images such as T2 weighted MRI is to segment edema/infiltration
region which is generally not observable in T1 images. Although the glial tumors
infiltrate beyond the enhanced margin and edema/infiltration region might be of
interest to fractionated radiotherapy in general, it is not possible to distinguish
edema and infiltration, so usually this region is not included in primary target
planning of radiosurgery, particularly in Cyberknife [22, 23, 24].
On the other hand, population atlases provide an important prior to improve
segmentation by measuring the deviation from the normal brain. Deformable reg-
istration of brain images with tumor to the population atlas is an extremely chal-
lenging problem and still an active research area due to intensity variations around
the tumor mainly caused by edema/infiltration, and the tumor mass effect, which
also deforms the healthy tissue morphology [18]. In some studies, affine registration
has been used for this purpose, however misalignment issues arise, especially where
there is a large deformation of the brain structures [22, 25].
Comparison to the works in the literature that use different approaches and other
image types is difficult as that would require the use of the same datasets by different
groups with evaluation performed by similar measures. For this reason, only the
results of some studies are given, instead of a detailed comparison. Although, using
manual expert segmentations as the ground truth, different performance measures
such as Dice Overlap, Jaccard Index, False Positive and Negative Volume Fractions
(FPVF, FNVF) were used in the literature, (Dice) Overlap is used as a common
measure for a comparison to previous methods here (see Appendix A for definitions
and conversions). With their automatic, multi-modal, atlas based method, Prastawa
et.al. have reported 86.7% average overlap on a small dataset of only 3 patients
with an average 1.5 hour processing time [22]. In more recent studies, Menze et.al.
reported 60% average overlap on 25 glioma patients and Gooya et.al. reported
74.5% average overlap on 15 glioma patients with about 6-14 hours of processing
time [25, 18]. In contrast, Liu et.al. reported 95.6% average overlap on only a
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subset of well-performing 5 patients over a 10 patient dataset using fuzzy clustering
on only FLAIR images. It should be noted that the latter method needs intensive
user interaction and correction as 8.4 minutes per patient on the average [23].
The popular trend in the area, as in the aforementioned approaches, is to be
able to combine information from different sources to obtain a better segmentation.
However, attempts to develop better algorithms from the image processing perspec-
tive that work on a particular MRI protocol continue in parallel not only to obtain
proper information from each channel to be combined, but also due to the practi-
cal need to routinely quantify tumors in a clinical environment [23]. Therefore, in
this study, we focused on an efficient and robust segmentation of brain tumors on
Contrast Enhanced T1-weighted MR images with minimal user interaction.
Region-based active contour models are widely used in image segmentation [26].
In general, these region-based models have several advantages over gradient-based
techniques for segmentation, including greater robustness to noise. However, classi-
cal active contours had the problem of being “only as good as their initialization”,
even when using level-set surfaces in 3D. Because the tumor class does not have a
strong spatial prior, many small structures, mainly blood vessels, are classified as
tumor as they also enhance with contrast. Ho et.al. used fuzzy classification of pre
and post contrast T1 images to obtain a tumor probability map to evolve a level-set
surface [27]. Liu et.al. have adapted the fuzzy connectedness framework for tu-
mor segmentation by constructing a rectangular volume of interest selected through
identifying the first and last slice of the tumor and specifying a set of voxels in the
tumor region [23].
Interactive algorithms have become popular for image segmentation problem in
recent years. Graph based seeded segmentation framework has been generalized
such that Graph-cuts (GC) [28], random walker (RW) [29], shortest paths, and
power watersheds [30] have been interpreted as special cases of a general seeded
segmentation algorithm, which solves a minimization problem involving a graph’s
edge weights constrained by adjacent vertex variables or probabilities. In [31], the
connection between GC, RW, and shortest paths was shown to depend on different
norms: L1 (GC); L2 (RW); L∞ (shortest paths), in the energy that is optimized.
Geodesic distances between foreground and background seeds were also incorporated
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into other shortest path-based segmentation algorithms by [32] and [33].
Although it was reported that the shortest paths and RW produce relatively
more seed-dependent results, it can be argued that the global minimum of an image
segmentation energy is worth as good as the ability of its energy to capture under-
lying statistics of images[34], and a local minimum may produce a solution closer
to the ground truth than that of a global minimum. Hence, with good prior infor-
mation provided as in the case of a seeded image segmentation problem, efficiently
finding a good local minima becomes meaningful and worthwhile.
On the other hand, cellular automata (CA) algorithm motivated biologically
from bacteria growth and competition, is based on a discrete dynamic system de-
fined on a lattice, and iteratively propagates the system states via local transition
rules. It was first used by Vezhnevets et.al. [35] (Grow-cut) for image segmentation,
which showed the potential of the CA algorithm on generic medical image problems.
However, Grow-cut was not designed for specific structures, such as tumors, which
display heterogeneous content such as necrotic and enhancing tissue. Moreover,
anatomic structures typically have relatively smooth boundaries, however, Grow-
cut tends to produce irregular and jagged surface results, and only an ad-hoc way
of smoothing was introduced.
In this chapter, we re-examine the CA algorithm to establish the connection of
the CA-based segmentation to the graph-theoretic methods to show that the iter-
ative CA framework solves the shortest path problem with a proper choice of the
transition rule. Next, as our application is in the clinical radiosurgery planning,
where manual segmentation of tumors are carried out on contrast enhanced T1-MR
images by a radio-oncology expert, we modify the CA segmentation towards the
nature of the tumor properties undergoing radiation therapy by adapting relevant
transition rules. Finally, a smoothness constraint using level set active surfaces is
imposed over a probability map constructed from resulting CA states. Following
a brief background on seeded segmentation methods in Section 2.2, we present our
framework for brain tumor segmentation in Section 2.3, and demonstrate its per-
formance via validation studies on both synthetic, and radiation therapy planning
expert-segmented data sets in Section 2.4, followed by conclusions in Section 2.5.
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2.2 Background
2.2.1 Seeded Image Segmentation
Given an undirected graph G = (V,E) with vertices v ∈ V and edges e ∈ E, a
weighted graph assigns a value wij (typically real and non-negative) to each edge eij
between vertices vi and vj. In image segmentation problems, vertices are correspond-
ing to image pixels, while edge weights are similarity measures between neighboring
pixels based on image features (e.g. intensities). Each vertex vi has an attribute xi,
which is an indicator of the probability of a label (e.g. a foreground and a back-
ground label). With the foreground F and background B seeds supplied by the user,
the labeling problem is solved by:
xopt = argmin
x
[ ∑
eij∈E
(wij|xi − xj|)q
] 1
q
s.t. x(F ) = 1, x(B) = 0, (2.1)
In the final solution, the vertices which have the value xi > 0.5 are labeled as
foreground and xi < 0.5 are labeled as background. The solution has been shown to
converge to Graph-cuts for q = 1, random walker for q = 2, and shortest paths for
q =∞ [31]. The Eq. 2.1 represents the general optimization problem of labeling in
graph-theoretic image segmentation. We will show that this optimization problem
for q =∞ can be solved by a CA-based algorithm.
2.2.2 Cellular Automata in Image Segmentation
A cellular automata is basically a computer algorithm that is discrete in space and
time, and operates on a lattice of cells [36]. Since it was first proposed by Von
Neumann and Ulam [37], Cellular Automata has attracted researchers from various
fields in both physical and social sciences because of its simplicity, and potential in
modeling complex systems [38].
Each individual cell is in a specific state and changes synchronously depending
on the states of some neighbors as determined by a local update rule [39]. They
are parallel, local and homogeneous, since the state of any cell depends only on the
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states of the local neighbors at the previous time step and the update rules are same
for every cell.
Formally, a cellular automaton (CA) is a triple A = (S,N, δ), where S is a
nonempty set, called the state set, N is the neighborhood, and δ : SN → S is the
local transition function (rule); SN , which is the argument of δ, indicates the states
of the neighborhood cells at a given time, while S, which is its value, is the state of
the central cell at the next time step[36].
Although the usual definition for “Cellular Automata” is in favour of a finite state
set (discrete and bounded), continuous state sets in which the states are real numbers
are also used in CA literature under the name “Continuous CA” or “Coupled Map
Lattices” [40, 41, 42, 35, 43, 44]. A detailed discussion and some of the issues that
can arise while using a continuous state set on a finite machine are given in [40, 41].
There are various attempts of using CA in image processing problems including:
Image enhancement (sharpening and smoothing) [45], image filtering, edge detection
[36], and image segmentation (Grow-cut) [35].
Grow-cut method uses a continuous state cellular automata to interactively la-
bel images using user supplied seeds. The cells are corresponding to image pixels,
and the feature vector is RGB or gray scale intensities. The state set S(θ, l, ~C) for
each image pixel consists of a “strength” value θ in a continuous interval [0, 1], a
label l and an image feature vector ~C. The automata is initialized by assigning
corresponding labels at seeds with a strength value between 0 and 1 where a higher
value reflects a higher confidence in choosing the seed. Strengths for unlabeled
cells are set to 0. A pseudo code for the Grow-cut algorithm is given below [35]:
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// For each cell ...
for ∀p ∈ P
// Copy previous state
lt+1p = l
t
p
θt+1p = θ
t
p
// Neighbors try to attack current cell
for ∀q ∈ N(p)
if g(‖~Cp − ~Cq‖2) · θtq > θtp
lt+1p = l
t
q
θt+1p = g(‖~Cp − ~Cq‖2) · θtq
end if
end for
end for
where g is a pixel similarity function bounded to [0, 1] depending on the image
features i.e.
g(x) = 1− x
max ‖~C‖2
(2.2)
where the argument x is for instance, the absolute difference between the intensities
of two neighboring pixels.
The surprising success of this simple algorithm, especially on medical images,
motivated us to further analyze the algorithm. We showed that the result of the
iterations of this algorithm converges to that of the shortest paths algorithm by mod-
ifying the similarity function used: g(x) = e−x (see Section 2.3.1). We note that, the
original similarity function used in Grow-cut (Eq. 2.2) is a first order approximation
to the one we utilized. In connecting shortest paths to cellular automata framework,
maximizing the product of the edge weight wij (defined in Eq. (2.12) in the Sec-
tion 2.3.1), was shown to be equivalent to minimizing the sum of the −logwij’s,
i.e. ||∇ij||’s, resulting in the shortest path between a seed node to any non-seed
node in the graph over the negative logarithm edge weights. These weights can be
interpreted similarly to the reciprocal weight w−1ij defined in Sinop and Grady [31],
which was shown to infer a connection between the shortest path algorithm and the
general seeded segmentation optimization Eq. (2.1) with L∞ norm minimization.
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Simultaneously and independently from our work, it has also been shown that the
Grow-cut algorithm is equivalent to the Belman-Ford algorithm, which calculates
the shortest paths on a weighted graph [44]. However, there, the motivation and
emphasis was on fast hardware implementation of the CA algorithms, due to both
increasing availability of low cost graphical hardware (GPUs), and CA algorithm’s
suitability to run on parallel processors.
Shortest path idea was utilized in other works such as [46], where the Eikonal
equation was solved with two different boundary conditions constructed from fore-
ground and background seeds. Image-dependent speed functions were inserted into
the right handside of the Eikonal equation, whose solutions led to two distance func-
tions: shortest paths of each pixel from the foreground seeds and the background
seeds. For each pixel, the smaller distance to the foreground seeds produced the
resulting segmentation.
2.3 Method
In this section, the complete segmentation framework to segment brain tumors and
the necrotic regions enclosed is presented in detail. Shortest path calculation using
cellular automata iterations is given in Section 2.3.1. An overview of the algorithm
with the pseudo-code of the implementation is given in Section 2.3.2. Major steps of
the algorithm is explained in detail in sections 2.3.3, 2.3.4, 2.3.5 and 2.3.6 followed
by the datasets and methods used for performance evaluation in Section 2.3.7.
2.3.1 Cellular Automata: its Connection to Graph Theo-
retic Methods
A graph consists of a pair G = (V,E) with vertices (nodes) v ∈ V and edges e ∈
E ⊆ V × V . The weight of an edge, eij, is denoted by wij and is assumed here to
be nonnegative and undirected (i.e., wij = wji). We will use closed neighborhood
NG[v] where vi ∈ NG(vi). The edge weights are similarity measures calculated
using measured data (e.g. voxel intensity) for vertices: wij = f(Ii, Ij) ∈ (0, 1] and
self-similarity wii = 1. State of a vertex s(vi) = si is specified with a real value
x(vi) = xi ∈ [0, 1] and a label li ∈ {BG,FG, · · · } pair. Starting with initial states
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of vertices, in each iteration, vertices of graph G is updated by the following rule:
lt+1i = l
t
i∗ and x
t+1
i = wi∗ix
t
i∗ where i
∗ = arg max
j∈NG[vi]
wjixj (2.3)
Note that since the vertex itself is also included in its neighborhood, Eq. (2.3) also
covers the static case:
st+1i = s
t
i if xi ≥ wjixj for ∀vj ∈ NG[vi] \ vi (2.4)
Vertex states are initialized by user supplied seeds pi ∈ P such as:
s0(vi) = (1, l(pi)) for vi ∈ P and s0(vi) = (0, ∅) for vi /∈ P (2.5)
This map converges since
∑
i xi is upper-bounded and monotonically increasing:
lim
t→∞
st+1i = s
t
i for ∀vi ∈ V (2.6)
Now, let us derive some properties on the final map. Consider any vertex vi of a
graph G, and assume that a latest update occurred on this vertex at time ti. The
vertex which updates vi is vi∗ . Final state for vi is:
st≥tii = (wi∗ix
ti
i∗ , l
ti
i∗) (2.7)
If any update occurs on vi∗ at time ti∗ ≥ ti by vi∗∗ , this should satisfy the condition:
xti∗i∗ = wi∗∗i∗x
ti∗
i∗∗ > x
t<ti∗
i∗ that gives wi∗ix
ti∗
i∗ > wi∗ix
t<ti∗
i∗ (2.8)
However, this will also cause an update on vi at t > ti∗ > ti, which violates the
condition in (2.7). Then, at the converged map, there exists a neighbor vi∗ for each
vertex vi such that:
si = (wi∗ixi∗ , li∗) (2.9)
If we go one step further:
si∗ = (wi∗∗i∗xi∗∗ , li∗∗) and si = (wi∗iwi∗∗i∗xi∗∗ , li∗∗) (2.10)
We can follow this path for any vertex until we reach a seed which is never updated:
s(vi) = (
∏
Ω(pi→vi)
wjk, l(pi)) (2.11)
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Therefore, this algorithm cuts the graph G to independent subgraphs for each seed,
consisting of spanning trees with seeds at root nodes.
If we set edge weights depending on similarity of image (I : R3 → R) neighbor-
hoods as:
wjk = e
−β||∇jkI|| (2.12)
where ||∇jkI|| denotes a Euclidean norm on the difference between intensities of two
adjacent vertices vj and vk. Maximization of the product of wjk’s along the path Ω
becomes equivalent to minimization of the summation of ||∇jkI||’s along the same
path.
∑
Ω(pi→vi) ||∇jkI|| is a discrete approximation to a geodesic or shortest path
between the seed pi to a voxel vi. Each voxel is then assigned to the foreground label
if there is a shorter path from that voxel to a foreground seed than to any background
seed, where paths are weighted by image content. With this interpretation, cellular
automata algorithm solves the shortest paths energy form formulated in [31].
The equivalence, which we showed, between CA updates by Eq. (2.3) and short-
est path algorithm is illustrated in Fig. 2.1.
The main advantage of using CA algorithm is its ability to obtain a multilabel
solution in a simultaneous iteration. Another advantage is that the local transition
rules are simple to interpret, and it is possible to impose prior knowledge, specific
to the problem, into the segmentation algorithm.
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Figure 2.2: Steps of the proposed tumor segmentation method: see text for expla-
nations.
2.3.2 Tumor-cut Algorithm
Steps of the proposed cellular automata based tumor segmentation algorithm is
shown in Fig. 2.2. First, (a) the user draws a line over the largest visible di-
ameter of the tumor; (b) using this line, a VOI is selected with foreground(red)-
background(blue) seeds; (c-d) tumor CA algorithm is run on the VOI for each two
sets of seeds (for the foreground and background) to obtain strength maps for fore-
ground (c) and background (d) at each voxel; (e) two strength maps are combined
to obtain the tumor probability map PT (Eq. (2.16)); (f) a level set surface is ini-
tialized at PT = 0.5 and the map PT is used to evolve the surface which converges
to the final segmentation map (g). Finally, (i) the necrotic regions of the tumor is
segmented using a CA-based method with the chosen enhanced and necrotic seeds
in (h).
A pseudo code of the Tumor-cut algorithm is given below:
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for ∀l ∈ {Tumor,Background}
// Initialize
for ∀p ∈ P
if p is a seed of class l, x0l,p = 1, else x
0
l,p = 0
end for
Do until convergence
// For each cell ...
for ∀p ∈ P
// Neighbors try to attack current cell
for ∀q ∈ N(p)
Find q∗: q with maximum g(p, q) · xtl,p
xt+1l,p = g(p, q
∗) · xtl,q∗
end for
// Copy previous state
xt+1l,p = x
t
l,p
end for
end do
end for
// Combine strengths for tumor and background to obtain
tumor probability map
PT = ln(xBg)/(ln(xBg) + ln(xT )) Eq. (2.16)
// Evolve the tumor surface via a level set embedding
∂S
∂t
= (u− v)(u+ v − 2PT )N
// where u, v are the means inside and outside the surface,
and N is the unit normal vector to surface S.
// Segment necrotic parts within the segmented tumor
volume.
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2.3.3 Seed Selection Based on Tumor Response Measure-
ment Criteria
In “Response Evaluation Criteria In Solid Tumors” (RECIST), which is a widely
used procedure to evaluate the treatment response of the solid tumors, tumor
progress is classified by measuring the longest in plane tumor diameter in one dimen-
sion (axial, coronal, sagittal)[47]. Our seed selection algorithm employs the same
idea to follow the familiar clinical routine to which the clinicians are used to: the
volume of interest (VOI), the tumor seeds and the background seeds are determined
by using the line already drawn by the user to measure the longest diameter of the
solid tumor. Similarly, focusing on tumor segmentation problem, the seed selection
procedure starts with a single line drawn by the user along the longest visible di-
ameter of the tumor. Afterwards, the VOI and the seeds are computed as follows:
(i) The line is cropped by 15% from each end and thickened to 3 pixels wide to
obtain tumor seeds; (ii) VOI is selected as the bounding box of the sphere having a
diameter 35% longer than the line; (iii) One-voxel-wide border of this VOI is used
as background seeds(see Fig. 2.2a, 2.2b).
Since the VOI is completely bounded by the background seeds, each path con-
necting inside and outside the VOI is blocked by a seed. Then, the result of labeling
using only the data inside the region is equivalent to using the whole volume whereas
the computation time is significantly reduced.
One obvious drawback is that the user draws the line on only a single slice of
the tumor volume, hence it is not guaranteed that the depth of the tumor will also
coincide with the VOI. For determining the enlargement ratio for the bounding box
size, the percentage of the volume enclosed in the sphere to the total tumor volume
is calculated for different enlargement ratio values, and the results are plotted in
Fig. 2.3. For our data set, %100 coverage was achieved with 2.00 times enlargement.
We used 1.35, which covers %99 of all tumors with 5 different initializations, which
gave a reasonable trade-off between the 3D inclusion of the whole tumor versus the
computation time increase due to enlargement of the volume. Furthermore, the
average Dice Overlap between the sphere drawn around the longest diameter line
and the tumor is found to be 56.7 ± 16.1 percent, which confirms the sphericity
assumption on solid tumors.
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Figure 2.3: Change of average coverage with enlargement ratio.
In occasional cases of slightly concave-shaped tumors, the maximum diameter
line will not be enclosed by the tumor completely. Even in these cases, the algorithm
can perform the segmentation successfully if an input 1D line is correctly drawn
to fall inside the tumor region. The line enlargement parameter selected for VOI
formation is determined by taking such cases into account, hence, the VOI contains
the whole tumor.
2.3.4 Adapting Transition Rule to Tumor Characteristics
In the tumor segmentation application, the cells or nodes in cellular automata frame-
work correspond to the MRI volume voxels in 3D. A 26-cell cubic neighborhood is
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used in 3D. MRI intensities are used as image features. The automata is initialized
with user supplied tumor and background seeds as explained in section 2.3.3 and
iterated by the following rule:
lt+1i = l
t
i∗ and x
t+1
i = g(i, i
∗)xti∗ where i
∗ = arg max
j∈Ni
g(i, j)xtj (2.13)
where g is a pixel similarity or transition function bounded to [0, 1], which is equiva-
lent to the edge weight function wij in the seeded segmentation framework. A typical
symmetric edge weight function depending on the image features, is given by the
absolute intensity difference or gradient magnitude between neighboring nodes i and
j:
g(i, j) = e−‖Ii−Ij‖ (2.14)
where Ii denotes the MR image intensity at node i.
In the seeded tumor segmentation application over contrast enhanced T1-weighted
MRI for heterogeneous tumors, which mostly consist of a ring enhancing region
around a dark necrotic core (and also irregular borders), most of the foreground
seeds fall in the necrotic region. This sometimes causes the segmentation algorithm
to get stuck at necrotic to enhancing tumor transition borders. To overcome such
problems, prior knowledge that tumor voxels are brighter in post contrast T1-MRI
can be utilized. This can be achieved by modifying the transition function g(i, j)
by inserting a spatially-varying parameter:
g(i, j) =
 e−β‖Ii−Ij‖ if Ii > Ij and lj = Tumore−‖Ii−Ij‖ otherwise (2.15)
The intuition here is based on the observation that the enhancing tumor cells are
brighter than the normal tissue, and more centrally located necrotic core is darker.
Therefore, by adjusting the β parameter, the weight reduction (i.e. the strength
loss) of a tumor state while passing through a ramp up gradient is adjusted to be
lower than other cases.
The effect of β parameter on the segmentation performance in terms of Dice
overlap measure is demonstrated in Figure 2.4. Although, some of the properties we
derived for the algorithm is no more valid, as due to asymmetric edge weight values,
we can no longer interpret the algorithm in the undirected graph framework as in
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Figure 2.4: Effect of β on the segmentation performance.
the Section 2.3.1, our experimental results revealed that the new tumor CA (tCA)
algorithm significantly improved the results obtained, especially on glioblastomas
[43].
2.3.5 Level Set Evolution on Constructed Tumor Probabil-
ity Map
Smoothing is an important prior in segmentation of brain tumors from post contrast
T1 images, because of three main reasons: First, an area surrounded by tumor tissue
is considered as a tumor region even the intensity characteristics are likely to be
healthy. Secondly, it is possible to include misclassified necrotic regions to tumor
region, which are usually surrounded by enhanced tissue. Finally, it is possible
to exclude nearby vascular structures that are enhanced by administration of the
contrast agent.
CA algorithm has the advantage of finding distance of each cell to the nearest
seed in a simultaneous iteration. However, the resulting strength map has only one-
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sided information, that is the distance to the other label classes is not available. In
order to create a probabilistic map, which can be used in an active surface (e.g. a
level set surface) evolution, the algorithm is run for each class with corresponding
class seeds (tumor and healthy) separately. Geodesic distances to the class seeds
can be calculated by D = −ln(x). Therefore, the tumor probability map is obtained
by combining the distances for tumor (DT ) and background (DB) as:
PTumor =
DB
DT +DB
(2.16)
The intuition with this probability construction, is that probability of being a tumor
is proportional to its distance normalized to the closest background seed. This
leads to choosing a higher probability of being a tumor when the distance to the
background seeds is large, and vice versa.
After obtaining the tumor probability map using the foreground and background
strength maps, an implicit 3-D level-set surface is initialized over the volume V
whose inside is given by {(X, Y, Z) : PTumor > 0.5}. The level set function whose
zero-level set represents an initial estimate of the tumor surface, S, is evolved on
PTumor with a piecewise constant region assumption of [26], however by using a local
Gaussian kernel to define inner and outer regions around the propagating surface
in order to compute regional statistics of the map, which constitute the inside and
outside sample means in this case. When the surface evolution converges, the final
tumor segmentation map is obtained.
The level-set-based smoothing over the constructed tumor probability map in
Eq. (2.16) constitutes an important part of the proposed method, as the clinical
expert segmentation, particularly in radiation oncology, mainly outlines the tumor
borders using contouring for radiotherapy planning as opposed to pixel by pixel la-
beling of the tumor carried out in some validation studies. As a result, our interactive
tumor segmentation includes an appropriate intelligent smoothing of the tumor bor-
ders based on the labeling results obtained from a graph-theoretic approach. This
is a process that is expected to simulate the expert’s manual contouring. The qual-
itative effect of adding the smoothing step over the CA result is shown in Fig. 2.5,
which exemplifies how the borders are smoothed after level set evolution over the
tumor probability map displayed in (b).
In order to determine the optimal choice for β parameter and smoothing weight-
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(a) (b) (c)
Figure 2.5: Effect of Smoothing. Example of tumor slice with vascularization and
necrotic part (a). Tumor probability map obtained by CA algorithm (b). Segmen-
tation result before smoothing (red), after smoothing (blue) and expert (yellow)
(c).
ing pair for tumor segmentation application, the algorithm is run for each β parame-
ter value varying between 0.4 to 1.0 whereas the smoothing weighting varies from 0.0
to 0.8. Using manual expert segmentations as ground truth, average Dice overlaps
obtained by each β parameter and smoothing level pair are plotted in Fig. 2.6. It
can be observed that β = 1 with 0.2 smoothing weight, which are used for validation
studies throughout the rest of the paper, give the best overlap performance.
2.3.6 Enhancing/Necrotic Segmentation
Quantification of the necrotic regions within a whole tumor is an important problem
in assessment of the tumor progress. Delayed radiation necrosis, which typically oc-
curs 3 months or more after treatment, is the primary risk associated with stereotac-
tic radiosurgery [48]. Necrosis of the tumor can occur as a result of the radiosurgery
as well as by the tumor progress itself like in high grade gliomas. Furthermore, fol-
lowing some radiosurgery treatment sessions (i.e. CyberKnife treatment of acoustic
neuromas), increase of the necrotic regions can be observed, which accompanies the
clinical improvement, without a significant change of the tumor core.
Necrotic class naturally arises in segmentation using multi protocol (T1, CE-
T1, T2, DWI etc.) intensity classifiers due to its different intensity characteristics
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Figure 2.6: Effect of β for different smoothing levels (increasing from dark to light)
on the average dice overlap performance on our clinical data set.
in different modalities. However, our aim in this study is to quantify the necrotic
and enhanced parts of the tumor using solely contrast enhanced T1 weighted MRI
volumes. This can be achieved by a two step sequential algorithm. Firstly, tumor
volume (including both enhanced and necrotic tissues) is segmented by the method
as described in sections 2.3.3-2.3.5 and then the necrotic and enhanced classes are
separated inside the whole tumor volume.
In CE-T1 MR images, necrotic parts of the tumor are observed as hypo-intense
for there is no blood flow into these regions where enhanced parts are hyper-intense.
Without any prior information, segmentation using an intensity threshold can be
applied by assigning necrotic label to the voxels lower than the chosen threshold
and enhanced label to those that are higher. To choose the threshold, we explored
using expectation maximization [49] and Otsu’s methods [50]. However, usually the
two classes are not separable on the intensity histogram even though they could be
separated easily on the image as seen on the sample case in Fig. 2.7.
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(a) (b)
Figure 2.7: (a) Tumor contour calculated by the proposed method, overlayed on a
sample MRI slice. (b) MRI intensity histogram of the 3D tumor volume.
(a)                              (b)
Figure 2.8: (a) Segmentation with a single threshold. (b) Necrotic and enhanced
thresholds to determine initial seeds.
Instead of using simple tresholding, connectedness was imposed by using the CA
algorithm with two thresholds as follows: Initially the voxels lower than a necrotic
threshold are labeled as necrotic seeds and higher than an enhanced threshold are la-
beled as enhanced seeds as in Fig. 2.8. Next, the voxels at remaining mid-intensities
are labeled by assigning the label of the nearest seed using the CA algorithm.
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(a)                               (b)
Figure 2.9: (a) Thresholds calculated by Otsu’s method and double thresholds cal-
culated by the proposed necrotic/enhanced segmentation method. (b) Enhanced
and necrotic seeds determined by the proposed method, used as an input to the CA
segmentation algorithm (Necrotic seeds in red and enhanced seeds in blue).
An algorithm to choose the two thresholds is devised as follows: First the number
of necrotic voxels (NOTSUnec ) and the number of enhanced voxels (N
OTSU
enh ) are roughly
calculated by using Otsu’s method. Then the necrotic and enhanced thresholds are
determined such that %25 of the necrotic volume is assigned as necrotic seed and
%25 of the enhanced volume is assigned as enhanced seed (see Fig. 2.9).
Tnec∑
I=0
H(I) = 0.25 ·NOTSUnec and
Imax∑
I=Tenh
H(I) = 0.25 ·NOTSUenh (2.17)
where H is the volume intensity histogram, NOTSUnec and N
OTSU
enh are rough volumes
estimated with Otsu’s method and Tnec and Tenh are the necrotic and enhanced
thresholds.
2.3.7 Data and Evaluation Methods
Validation studies of the developed method is carried out over three different datasets
of all contrast enhanced T1-MR images:
1. Synthetic datasets of simulated tumors from Utah [2]
Five synthetic brain tumor datasets, available online from University of Utah
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2 are used in the first part of the validation studies. The utilized data simu-
lates contrast-enhanced T1-weighted MR images with synthetically generated
tumors. The tumor probability maps are also available with the dataset for
validation purposes. This dataset is included in the performance evaluations
since the ground truth segmentation is readily available.
2. Harvard Brain Tumor Repository [51]
A tumor repository, which includes 10 tumors with multiple manual expert
segmentations on 2D slices, from Harvard [51], was utilized in the second
set of experiments, due to its availability online and providing a common
framework to compare performances of different algorithms. The repository
includes contrast enhanced T1-weighted MR images, acquired with SPGR
sequence at 0.9375x0.9375x1.5 mm contiguous sagital slices. Recently, the data
from this repository have been evaluated by a validation framework, known
as STAPLE [19], which calculates sensitivity, specificity, and total correct
fraction criteria for evaluation of the proposed method against multiple expert
segmentations. With Harvard brain repository data, it is possible to compare
intra- and inter-rater variation vs. the algorithm’s robustness.
3. Brain Tumor datasets obtained from our clinical Radiation Oncology site (ASM)
In radiosurgery planning of brain tumors, target tumor volume, which is de-
sired to receive sufficiently high dose, is outlined on MR images by a radio-
oncology specialist. A large dataset of brain tumor patients, who received
CyberKnife radiosurgery treatment in Anadolu Medical Center (ASM), Ko-
caeli, Turkey was utilized in the third set of experiments. MR images of 19
tumors of 14 patients were obtained by 1.5T MRI scanner located at the same
hospital as high resolution (≈ 0.5x0.5x1.0 mm) contiguous axial T1 weighted
3D SPGR MRI volumes (TE/TR = 3.16s/8.17s, FA=25) acquired after IV
injection of 10cc 0.5M Multihance Gd. Figure 2.10 demonstrates axial snap-
shots of a sample central slice for each tumor in the dataset. As the ground
truth for segmentation, we used the tumor contours outlined manually by a
radio-oncologist for radiosurgery planning.
2http://www.ucnia.org/softwaredata/5-tumordata/10-simtumordb.html
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Figure 2.10: Clinical data set used for validation studies.
In assessment of the tumor segmentation performance, for each of the tumor
cases, the following similarity criteria are utilized: Dice overlap is used to quantify
the overlap between obtained segmentation maps and the “true” segmentations as
given in Eq. A.0.1 of Appendix A. In addition, tumor volume error is calculated
as: (|V ol(Algorithm) − V ol(Manual)|/|V ol(Manual)|, where V ol(.) is the tumor
volume calculated over either the algorithm segmentation map or the manual seg-
mentation map accordingly. Mean, median, and maximum of the surface distances
are calculated using the minimum distances from the sampled points on the algo-
rithm segmentation surface to the manual segmentation surface.
Interactive segmentation method outputs do usually vary with respect to initial-
izations, and this is an important performance criterion in assessment of the quality
of a segmentation method. To measure the robustness of the proposed method, for
33
each tumor case, results with 5 different initialization lines are calculated and mean
and standard deviation for each criterion are reported in the tables. This is crucial
in showing the true performance of any segmentation method that requires an ini-
tialization, and it should be reported rather than result of an arbitrary initialization,
typically from a maximally performing case.
For Harvard tumor repository and our clinical dataset, measured physical tumor
volumes are compared using Bland-Altman analysis, which looks at the variation of
difference volume in mm3 between the real and estimated tumors vs. the average of
the two volume measurements. Typical evaluation with a Bland-Altman analysis,
is to check whether the results are scattered around the zero difference value within
±1.96 times standard deviation.
The result of the Tumor-cut algorithm is compared to that of the Graph-cut and
Grow-cut algorithms, on the clinical dataset. Graph-cut is included in comparison
for its popularity among graph based segmentation methods, and Grow-cut is chosen
since it is the first algorithm that uses CA for image segmentation. For each of the
tumor cases, Graph-cut, Grow-cut and Tumor-cut algorithms are run with identical
seed initializations. Average Dice overlaps and standard deviations of 5 different
initializations for three methods, are given as bar plots.
2.4 Results and Discussion
2.4.1 Validations on Synthetic Data
The performance measures, Dice overlap, mean, median, and maximum surface
distances and the volume percent error between the ground truth segmentation and
the result of the algorithm are reported in Table 2.1 for the synthetic dataset. The
standard deviations show the extent of performance for different realizations of the
initialization. The Dice overlap is on the average 83%. Due to the challenging case
5, the volume error increased, however, it was typically between 10±6 percent. The
mean ± standard deviations for the maximum surface distance is 6.8± 3.6mm, the
mean surface distance is 1.7±2.1mm, and the median surface distance is 1.5±2.3mm.
Although synthetically created, the Utah tumor dataset contains tumor scenarios
with low contrast difference between the tumor region and its background: for
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instance, the synthetic tumor labeled as case 5 is shown in Figure 2.11. The active
surface propagation over the constructed probability map aims at correction and
improvement of the segmentation by smoothing out the tumor borders, and avoiding
sharp protrusions, however, here due to the low intensity contrast between the tumor
tissue and the gray matter, the Tumor-cut performed worse than expected. This
low performance result obtained on the non-enhancing tumor case 5, reveals the
limitation of the method and its application to the tumors that are enhanced with
the contrast agent.
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(a)                   (b)                  (c)
Figure 2.11: Synthetic tumor case 5 in Table 2.1. (a) An MRI slice is depicted; (b)
Grow-cut result (red); (c) Tumor-cut method which includes a level set segmentation
over the constructed probability map from tCA (red). Blue: Ground truth.
2.4.2 Validations on Harvard Brain Tumor Repository
Sensitivity, specificity and total correct fraction values evaluated by STAPLE are
given in Figure 2.12 for Harvard tumor dataset. Sensitivity of the method is not
statistically different from the expert results (within ±1.96 standard deviation),
assuming an underlying Gaussian distribution of the variations around the mean.
Specificity and total correct fraction values, on the other hand, are generally higher
in the expert evaluations, however, the proposed method also performs at about
0.996±0.005 in specificity and 0.995±0.005 in total correct fraction. One can observe
that tumor Case 8 performs especially poorly, which is depicted in Figure 2.13. Here,
tumor tissue depicts intensity levels close to those of the surroundings, and high,
continuous gradients of the complex background near the right boundary leads to a
spread-out probability map as shown in the figure.
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Figure 2.12: STAPLE evaluation results on Harvard Brain Tumor Repository.
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(a)                    (b)                   (c)
(d)                          (e)
Figure 2.13: Brain tumor repository data set case 8. (a) MR image slice; (b) gradient
magnitudes; (c) the probability map constructed by Eq.(2.16); (d) Tumor-cut result
without smoothing (in red), expert segmentation (in blue); (e) Tumor-cut-smoothed
shows a spread out isosurface around value 0.5, possibly due to the tumor tissue
depicting an intensity level close to its background and complex background with
high gradients near the right boundary.
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Figure 2.14: Bland-Altman plot of real and estimated physical tumor volumes (in
mm3) over Harvard Brain Tumor Repository. The dashed lines mark±1.96 standard
deviation values of the volume difference whereas the solid line marks its mean.
Table 2.2 shows the performance criteria statistics calculated for the Tumor-
cut method over the Harvard brain tumor repository dataset. The Dice overlap
over 10 tumor cases is 89.3% on the average, however, goes up to 89.3 + 6.9 =
96.2% with better initialization scenarios. The volume percent error is 21.4± 21.7,
which is degraded by the Tumor case 8, the worst performing one. We note that
we included all the results including low performance ones rather than reporting
that the algorithm failed for some tumors and excluding them as outliers from the
statistics. Without such “outlier” cases, the overall statistics would as expected
indicate higher success rates. The mean ± standard deviations for the maximum
surface distance is 7.3± 4.7mm, the mean surface distance is 2.1± 1.8mm, and the
median surface distance is 1.5 ± 1.4mm. Particularly, the median surface distance
shows that the estimated tumor surfaces are fairly close to the expert outlined
surfaces.
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A Bland-Altmann analysis of the physical volume calculations, based on Tumor-
cut segmentation method, is shown in Figure 2.14. Other than one failed case (case
8) as discussed above, the volume differences are inside the ±1.96 standard deviation
interval as desired. However, we observed an overestimation in the measured vol-
umes in the Harvard brain dataset. We found two possible reasons for this positive
volume bias: (i) checking the tumor tissue image characteristics over the provided
contrast enhanced T1-MRI, a smooth transition from the tumor contrast region to
its surroundings could be seen (e.g. see Figures 2.13), which led to an oversmooth-
ing in the constructed probability map, hence led to a slight over estimation; (ii)
more likely reason is the clinical context and style of the manual segmentation maps.
The experts who performed the tumor outlines preferred to draw the tumor border
contours just inside the observed tumor edges. As our algorithm is motivated by
the radiation therapy clinical application, the radiation oncology experts most likely
draw the tumor border just outside the observed tumor edges rather than drawing
them inside. The reason for this obvious preference is the fact that in the radiation
therapy planning, a buffer zone is included around the tumor to ensure the inclusion
of the enhancing tumor tissue on the rim of the tumor mass. This led us in our de-
velopment of a tumor segmentation method for mainly radiation therapy planning,
to design the level set smoothing stage over the tumor probability maps. We think
this explains the volume over estimation by our method over the Harvard tumor
dataset.
2.4.3 Validations on Tumors that undergo Radiation Ther-
apy Planning
The clinical classification of tumors along with the different segmentation perfor-
mance criteria of the Tumor-cut algorithm over the clinical radio-oncology dataset
is tabulated in Table 2.3. The Dice overlap is 80.1 ± 6.9 on the average, volume
percent error is 21.9± 12.1. In order to demonstrate the difficulty level of segmen-
tation on the clinical radio-oncology dataset tumors, snapshots from a central axial
slice over the VOI are given in Figure 2.10. The heterogeneous intensity character
with both necrotic and enhancing tumor tissue content can be observed, and this
heterogeneity leads to errors in existing segmentation methods. A comparison will
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be given in Figure 2.16 later. The mean ± standard deviations for the maximum
surface distance is 5.5± 2.7mm, the mean surface distance is 1.2± 0.6mm, and the
median surface distance is 1.0± 0.4mm. Another note here is the observation that
the surface distance measures indicate an overall/major proximity of the expert-
drawn and algorithm-computed surfaces, whereas the Dice overlap criterion is not
as high as expected. In general, these two types of criteria (Dice overlap and surface
distances) are not correlated. For instance, for small tumors (e.g. volume less than
1.5cc), we observed a low overlap score even though the surface distances between
the manual delineations and the algorithm output surfaces were not relatively high.
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Figure 2.15: Bland-Altman plot of real and estimated tumor volumes on Clinical
Data Set. The dashed lines mark ±1.96 standard deviation values of the volume
difference whereas the solid line marks its mean.
A Bland-Altman analysis for physical tumor volume measurements is presented
in Figure 2.15 which shows that the 90% of the volume differences lie within ±1.96
standard deviations around the mean difference, which is slightly below zero. As we
noted before, slight under estimation or over estimation can be possibly due to the
expert manual segmentations having a positive or negative bias.
Figure 2.16 presents Dice overlap comparison results among the Graph-cuts,
Grow-cut, and the proposed Tumor-cut method. The results we observed with
the Graph-cuts approach exhibits similar problems reported before in [30] such as
shrinking bias due to minimum cut optimization. The shortest path algorithms,
e.g. CA-based methods, showed lack of the shrinking bias problem. The proposed
Tumor-cut algorithm exhibits a lower coefficient of variation (std/mean) on the
average compared to the other methods used in validation, where the coefficient of
variation was 0.5373 (Graph-cuts); 0.0393 (Grow-cut); 0.0238 (Tumor-cut). Paired
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Figure 2.16: Comparison of Dice overlap for Graph-cut, Grow-cut and the proposed
method on clinical radio-oncology data set, demonstrates improved overlap with the
proposed method over this relatively more challenging tumor data. Black vertical
bar indicates ± standard deviation over 5 different initializations.
t-test comparison of Grow-cut and Tumor-cut demonstrates a statistically significant
improvement in Dice overlaps (p = 9.91 × 10−21), mean surface distances (p =
5.37× 10−11) and volume errors (p = 1.60× 10−11) with the Tumor-cut method.
Qualitative Results
We present 3D qualitative segmentation results from the clinical dataset on sample
2D slices in Figure 2.17. The mixed necrotic and enhancing tumor tissue content,
as well as cluttering neighboring structures such as vessels can be observed. These
challenging scenarios exemplify the difficulty level in the segmentation problem,
for whose solution interactive algorithms are regarded by the physicians as more
feasible than fully-automated ones. The level of interaction in the proposed tumor
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Figure 2.17: Sample slices of segmentation results obtained by the proposed method
on challenging cases of the clinical data set.
segmentation algorithm is minimal given by a single line along a 2D axial major
diameter of the given tumor. A simple initialization that lasts only 1-2 seconds
for the Tumor-cut algorithm, lead to reasonably well tumor delineations, which are
of important value in quantification of the volume change, as well as necrotic and
enhancing tumor tissue content change between a baseline and follow-up study in
the clinics for assessment of radiotherapy response. We present the results of the
necrotic tissue segmentation in the next subsection.
2.4.4 Enhancing/Necrotic Core Segmentation Results
In Section 2.3.6, we presented a CA-based method for labeling of necrotic and en-
hancing tumor tissue content after whole tumor boundary segmentation. We com-
pared the proposed method against EM and Otsu thresholding methods, both of
which were based on finding a single “optimal” threshold over the intensity distri-
bution within the tumor volume. In the proposed method, two thresholds are first
selected in order to set seeds for the necrotic and enhancing tumor tissue, and af-
terwards, cellular automata algorithm is run and the results are validated against
several 2D slices, over which the necrotic pixels were labeled by the expert radiolo-
gist in our team. In order to measure the improvement by imposing connectedness
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with the proposed CA algorithm, the maximum overlaps obtained using single and
double threshold methods are also reported by evaluating the algorithms using every
possible threshold values. Even though it is important for the clinicians to have the
capacity to quantify the change in the necrotic content of the tumor after radiation
therapy, this differentiation within tumor content is not typically carried out in the
clinical routine. Table 2.4 presents Dice overlap results of necrotic tissue segmenta-
tion for the tumors for which manual labels were available. Although this is a too
small dataset to arrive at conclusions, the proposed method performs reasonably
well for this problem. Qualitative results are given in Figure 2.18. Typical patterns
of dark necrotic core in the center and bright enhancing rim can be observed in rows
2-5, and to an extent in row 1. The result in row 6 gave the lowest performance
because small islands of necrotic regions with ambiguous low contrast were missed
by all three algorithms.
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Figure 2.18: Necrotic segmentation results for 6 different tumors on each row. Left-
To-Right: Manual Expert Delineation; EM Segmentation; Otsu Thresholding; CA
Tumor Segmentation.
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2.5 Conclusion
We presented a segmentation algorithm for the problem of tumor delineation which
exhibit varying tissue characteristics. As the change in necrotic and enhancing
part of the tumor after radiation therapy becomes important, we also applied the
Tumor-cut segmentation to partition the tumor tissue further into its necrotic and
enhancing parts. We presented validation studies over a synthetic tumor database
and two real tumor databases: one from Harvard tumor repository and another
from a clinical database of tumors that underwent radiosurgery planning at Radi-
ation Oncology Department of ASM. The performance over particularly datasets
of highly heterogeneous tissue content demonstrated an overlap in the range 80%
to 90%, however, with a desired low surface distance error, average median surface
distances of 1.0mm to 1.5mm, respectively. Furthermore, performance change over
varying initial seeds were also reported as standard deviations, and shown to be
important in assessing true robustness of the proposed algorithm in real application
scenarios. The user interaction time is just a few seconds and typical computation
times vary between 1 second to 16 minutes (on a 3.17GHz dual processor worksta-
tion) depending on the volume of the tumor which ranges between 0.5cc and 32cc.
Due to inherent parallelity of the proposed algorithm, computation time can be
significantly reduced. However, in the case of multiple metastases, user interaction
time increases with the number of tumors, as the user should draw one line for each
tumor, and for instance such a problem was addressed in RECIST guideline 1.1 [52]
which limited the maximum number of tumor cases to be processed to 5.
Strengths of the proposed method include its simple interaction over a single
slice and less sensitivity to the initialization (demonstrated by lower coefficient of
variation values), its efficiency in terms of computation time, and robustness with
respect to different and heterogeneous tumor types. Choosing the contrast enhanced
T1 modality limits the application to the tumors that are enhanced with the con-
trast agent, excluding the edema/infiltration region around the tumor. For the
targeted clinical application of radiosurgery planning, using a single modality is an
advantage due to the computational efficiency and ease of use. However, in a multi-
modal scenario, it could be possible to design new transition functions adapted to a
given modality and also optimize the parameters. Later, the probability maps con-
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structed from each modality could be combined to obtain the final segmentation.
Future work includes assessment of the tumor response to therapy, built on the
given segmentation framework, which was encouraged by the clinical experts due
to reasonable and acceptable success rates of the algorithm. Attempts presented in
this paper to quantify change in necrotic and enhancing tumor tissue content is also
welcomed to be of high clinical interest, particularly in radiation oncology practice.
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Chapter 3
Multimodal Extension of the
Tumor-cut Method and
Evaluation on the BraTS Dataset1
3.1 Introduction
In Chapter 2, a novel method for segmentation of tumors from a single MRI se-
quence, the contrast enhanced T1-weighted MRI, is presented. However, incorpora-
tion of the multi-modal imaging data from different MR sequences, diffusion MRI,
and/or even Positron Emission Tomography (PET), is an emerging approach for
tumor segmentation. This would bring a wider spectrum of information with dif-
ferent intensity characteristics from various medical images of for instance different
relaxation characteristics as in T1-weighted or T2-weighted MRI. Because of their
unpredictable appearance and shape, segmenting brain tumors from multi-modal
imaging data is one of the most challenging tasks in medical image analysis. Al-
though many different segmentation strategies have been proposed in the literature,
it is hard to compare existing methods because the validation datasets that are used
differ widely in terms of input data (structural MR contrasts; perfusion or diffusion
data; ...), the type of lesion (primary or secondary tumors; solid or infiltratively
growing), and the state of the disease (pre- or post-treatment).
1The work presented in this chapter appeared in Proceedings of MICCAI-BRATS 2012 October
1st, Nice, France and is in preparation for joint paper submission.
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In order to gauge the current state-of-the-art in automated brain tumor seg-
mentation and compare between different methods, a multimodal Brain Tumor Seg-
mentation (BraTS) challenge is organized that is held in conjunction with the 15th
International Conference on Medical Image Computing and Computer Assisted In-
tervention (MICCAI 2012) on October 1st, 2012 in Nice, France. For this challenge,
a large dataset of brain tumor MR scans including low- or highgrade glioma cases
with manually labeled segmentation maps are made publicly available. Addition-
ally, realistically generated synthetic brain tumor datasets are provided for which
the ground truth segmentation is known. The details of the available MR images
and the expert labeling protocol are given in section 3.3.
Tumor-cut method, which is originally developed for segmentation on contrast
enhanced T1 weighted MR modality as described in detail in Chapter 2 and in [53],
is extended to process multi modality MR images (see Section 3.2). The BraTS
challenge served to evaluate the value of the multi modality Tumor-cut method
within the current state-of-the-art techniques.
3.2 Methods
The semi-automatic tumor segmentation method, as described in detail in the
“Tumor-cut” article [53] and in Chapter 2, specifically targets the gross tumor vol-
ume (GTV) and the necrotic regions of the brain tumors on contrast enhanced
T1-weighted MR images, requiring an initialization by drawing a line through the
maximum diameter of the tumor as in the “Response Evaluation Criteria In Solid
Tumors” (RECIST) guidelines [52]. For the BraTS challenge, the method was ex-
tended to multi-modal MRI to include also the labels for edema and non-enhanced
regions. Tumor-cut’s approach to fuse different MR modalities is to apply the orig-
inal method to each channel seperately and then combine the segmented volumes
by basic set operations based on the type of the modality. For each channel, a seg-
mentation is initialized by drawing the maximum observable diameter of the tumor
and performed independently (see Figure 3.1). For FLAIR images, whole hyper-
intense region is segmented as FLAIR volume (Vfl) and for T2 images only the core
abnormality is segmented as T2 volume (Vt2). Tumor core is segmented on contrast
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Figure 3.1: Maximum diameter line drawn by the user to initialize the algorithm
for CE-T1 (a), T2 (b) and Flair (c) modalities and the corresponding outputs, for
a sample high grade case. Manual labels overlayed on T1 for a sample slice (d).
enhanced T1 MRI (Vt1c) followed by the application of the necrotic segmentation
method to segment the necrotic regions within the tumor core (Vnec). For the low
grade cases, Vt1c and Vnec are set to empty, because the tumors were not enhanced
by the application of the contrast agent. Non-contrast enhanced T1 MR images
were used neither for high nor low grade cases. For FLAIR segmentation, only the
weight of the regularizer in the energy term for the level-set evolution is tuned to
allow resulting tumor surfaces to have higher curvatures. Label for each class is
determined by the following operations:
Necrotic = Vnec
Enhanced = Vt1c \ Vnec
Non− enhanced = Vt2 \ Vt1c
Edema = Vfl \ (Vt2 ∪ Vt1c) (3.1)
For each case, user interaction takes about 1-2 minutes and typical run time is
around 10-30 minutes, depending on the size of the tumor, using a CPU (3.16 GHz).
However, the parallel nature of the algorithm allows GPU implementation, which
would reduce the processing time significantly.
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3.3 BraTS Dataset2
The first version of the dataset, which was used in the BraTS challenge in MICCAI,
consists of two label manual segmentation including edema and tumor core. After
a few months, the performances of the algorithms were evaluated on an improved
dataset consisting of 4-labels as described in detail in the following sections.
3.3.1 Image Types Used for Segmentation
The MR images used for tumor segmentation are given in the following list:
• T1-Weighted. T1-weighted, native image, sagittal or axial acquisitions, vari-
able slice thickness from 1 to 5 mm.
• Contrast Enhanced T1-Weighted: T1-weighted, post Gd image. Axial
3D acquisition, 1 mm isotropic voxel size.
• T2-Weighted. T2-weighted image, axial 2D acquisition, 2-4 mm slice thick-
ness.
• T2-Weighted Fluid Attenuated Inversion Recovery (FLAIR). T2-
weighted FLAIR image, axial or coronal or sagittal 2D acquisitions.
The images were taken from multiple centers and multiple scanners, therefore
image quality and acquisition parameters differ. Although the original acquisition
parameters are heterogeneous, all images are co-registered to the post-contrast T1
image and re-sampled to 1 mm.
3.3.2 Label Definitions
Although the general problem of defining tumor borders in infiltrative tumors still
exists, particular radiological criteria can be set to define such sub-domains. These
2Brain tumor image data used in this work were obtained from the MICCAI 2012 Challenge
on Multimodal Brain Tumor Segmentation (http://www.imm.dtu.dk/projects/BRATS2012) or-
ganized by B. Menze, A. Jakab, S. Bauer, M. Reyes, M. Prastawa, and K. Van Leemput. The
challenge database contains fully anonymized images from the following institutions: ETH Zurich,
University of Bern, University of Debrecen, and University of Utah.
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Figure 3.2: Tumor labels overlayed on a sample slice of a typical high grade glioma
case. Green: Non-brain, non-tumor, necrosis, cyst, hemorrhage (1). Yellow: Sur-
rounding edema (2). Brown: Non-enhancing tumor part (3). Blue: Enhancing
tumor core (4).
domains do not reflect strict biological correspondence and homogeneity but are
rather place-holders for similarly-looking regions. For instance, the definition of the
active tumor could simply be the high signal intensity regions on T1 Gd images.
However, in high grade tumors, there are non-necrotic, non-cystic regions that do not
enhance but they can be clearly separable from the surrounding edema. Another
problem is the definition of tumor center in low grades. In such cases, a certain
delimitation of the T2 hyperintense surrounding edema and the growing tumor is
sometimes possible, but they do not enhance. Therefore as shown in Figure 3.2, the
following set of labels is used to define intra tumoral sub-domains:
• Label 1. Non-brain, non-tumor, necrosis, cyst, hemorrhage
• Label 2. Surrounding edema
• Label 3. Non-enhancing tumor part
• Label 4. Enhancing tumor core
The definitions for labels 1,2 and 4, which are necrosis, edema and enhancing
tumor respectively are relatively common and easy to identify, whereas the label 3
57
Figure 3.3: Definition of the label 3 for high grade glioma cases. Left: Gross tumor
and edema regions are distinguishable on T2 images with different intensity and
texture characteristics. Center: Enhancing tumor volume, which appears hyper-
intense on contrast enhanced T1 weighted MR images, do not completely overlap
with gross tumor volume on T2-weighted images. Right: Corresponding labeling
where the region that is not enhanced with the contrast agent but appears as a part
of the gross tumor in T2 is labeled as non-enhancing in brown color (label 3).
might be confusing. The non-enhancing tumor core is the only category used for
delineating tumor centers in low grade gliomas, for there occurs no enhancement in
contrast enhanced T1 images. However, in high grade glioma cases, identification of
those non-enhancing regions of the tumor core requires parallel viewing of T1 and
T2 images as shown in Figure 3.3. The region that is not enhanced with the contrast
agent but appears as a part of the gross tumor in T2 is categorized as non-enhancing
tumor core and labeled with 3.
3.4 Results
The method is implemented on Matlab environment, running on a windows 7 work-
station, using mex files for core algorithms. The dataset is downloaded from the
“Virtual Skeleton Database” web site (http://www.virtualskeleton.ch/) and the on-
line system provided is used for the evaluation.
Both of the 2-label and 4-label dataset, are divided into two parts as “Train-
ing Dataset” and “Testing Dataset”. The manual labels of the training data were
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provided oﬄine to participants of the BraTS challenge as a ground truth to train
and tune the algorithms. The segmentation maps obtained on the MR images of
the test dataset are uploaded to the “Virtual Skeleton” server and the segmentation
performance measures are calculated by comparing with the ground truth, which is
hidden to the participants.
The results for each case of the “2-Label Training Dataset” are provided in
Section 3.4.1. The overall results, for the 2-label (Section 3.4.1) and 4-label (Sec-
tion 3.4.2) test/training datasets are given, compared to the performance of the
other techniques participated in BraTS Challenge.
3.4.1 Results on 2-Label Dataset
For each subset of the BraTS 2-Label Training Dataset, including high grade and
low grade, simulated and patient data, the Dice overlap scores obtained are given
as bar charts in Figs 3.4-3.7. For the 2-Label ”Testing Dataset”, which consists of 4
low grade and 11 high grade glioma cases, the results are given in Figs 3.8 and 3.9.
The overall Dice overlap, Jaccard scores, Sensitivity and Specificity results with
the standard deviations are reported in Table 3.1. The comparison of the Dice scores
obtained by tumor-cut method with the other techniques participated in the BraTS
challenge is given in Table 3.2.
Figure 3.4: Dice overlap results obtained on each case of the low-grade patient subset
of the 2-Label Training Dataset.
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Figure 3.5: Dice overlap results obtained on each case of the high-grade patient
subset of the 2-Label Training Dataset.
Figure 3.6: Dice overlap results obtained on each case of the simulated low-grade
subset of the 2-Label Training Dataset.
Figure 3.7: Dice overlap results obtained on each case of the simulated high-grade
subset of the 2-Label Training Dataset.
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Figure 3.8: Dice overlap results obtained on each case of the low-grade patient subset
of the 2-Label Testing Dataset.
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Figure 3.9: Dice overlap results obtained on each case of the high-grade patient
subset of the 2-Label Testing Dataset.
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Table 3.2: Tumor core and edema dice overlap percentages on 2-label testing dataset
for the participated groups of the BraTS Challenge.
Method High Grade Cases Low Grade Cases
(Tumor Core / Edema) (Tumor Core / Edema)
Hamamci et al. 69.4 / 53.9 32.4 / 3.3
Shin et al. 14.4 / 3.8 23.2 / 6.1
Bauer et al. 51.2 / 53.6 33.2 / 17.9
Zikic et al. 47.6 / 59.8 33.9 / 32.4
Subbanna et al. 13.3 / 6.9 0.1 / 0.0
Xiao et al. 33.7 / 53.9 22.4 / 27.9
Zhao et al. 5.8 / 0.3 0.0 / 0.0
3.4.2 Results on 4-Label Dataset
The 4-label patient dataset is divided into two parts as ”Training Dataset” and
”Testing Dataset”, that consist of 30 (10 low, 20 high grade) and 15 (4 low, 11
high grade) glioma cases respectively. The evaluation is done for 3 different tumor
sub-compartments, which are a combination of the 4-labels defined in Section 3.3.2,
as follows:
• Region 1: Complete Tumor (Edema + Enhancing + Non-enhancing + Necro-
sis)
• Region 2: Tumor Core (Enhancing + Non-enhancing + Necrosis)
• Region 3: Enhancing Tumor3 (Enhancing)
The average dice overlap, jaccard scores, specificity and sensitivity results with
the standard deviations for each subset of the 4-label dataset are reported in Ta-
ble 3.3. The comparison of the dice scores, positive predictive values and sensitivity
results obtained by tumor-cut method with the other techniques participated in the
BraTS challenge for testing and training datasets are given in Tables 3.4 and 3.5
respectively.
3Enhancing tumor region is not evaluated for the low grade glioma cases.
63
T
ab
le
3.
3:
A
ve
ra
ge
an
d
st
an
d
ar
d
d
ev
ia
ti
on
of
th
e
d
ic
e
ov
er
la
p
,
ja
cc
ar
d
,
sp
ec
ifi
ci
ty
an
d
se
n
si
ti
v
it
y
re
su
lt
s
ob
ta
in
ed
on
th
e
4-
la
b
el
B
ra
T
S
d
at
as
et
.
D
ic
e
O
v
er
la
p
J
a
cc
a
rd
S
co
re
S
p
ec
ifi
ci
ty
S
en
si
ti
v
it
y
co
m
p
le
te
co
re
en
h
a
n
ci
n
g
co
m
p
le
te
co
re
en
h
a
n
ci
n
g
co
m
p
le
te
co
re
en
h
a
n
ci
n
g
co
m
p
le
te
co
re
en
h
a
n
ci
n
g
T
es
ti
n
g
-
L
o
w
0
.5
5
±
0
.1
3
0
.4
0
±
0
.1
3
-
0
.4
6
±
0
.1
1
0
.3
2
±
0
.1
0
-
0
.4
9
±
0
.1
3
0
.3
3
±
0
.1
0
-
0
.7
1
±
0
.1
7
0
.7
1
±
0
.1
7
-
T
es
ti
n
g
-
H
ig
h
0
.7
8
±
0
.0
2
0
.6
3
±
0
.0
3
0
.5
9
±
0
.0
5
0
.6
5
±
0
.0
2
0
.4
8
±
0
.0
3
0
.4
5
±
0
.0
5
0
.7
2
±
0
.0
3
0
.5
7
±
0
.0
4
0
.6
3
±
0
.0
7
0
.9
1
±
0
.0
2
0
.8
5
±
0
.0
7
0
.7
0
±
0
.0
5
T
ra
in
in
g
-
L
o
w
0
.8
6
±
0
.0
1
0
.7
0
±
0
.0
2
-
0
.7
7
±
0
.0
2
0
.5
6
±
0
.0
3
-
0
.8
4
±
0
.0
1
0
.7
0
±
0
.0
3
-
0
.8
9
±
0
.0
1
0
.7
7
±
0
.0
5
-
T
ra
in
in
g
-
H
ig
h
0
.7
9
±
0
.0
2
0
.6
8
±
0
.0
3
0
.6
6
±
0
.0
5
0
.6
8
±
0
.0
4
0
.5
4
±
0
.0
3
0
.5
2
±
0
.0
4
0
.7
5
±
0
.0
3
0
.6
0
±
0
.0
4
0
.7
2
±
0
.0
7
0
.8
9
±
0
.0
2
0
.8
8
±
0
.0
2
0
.6
4
±
0
.0
5
64
T
ab
le
3.
4:
D
ic
e
ov
er
la
p
,
p
os
it
iv
e
p
re
d
ic
ti
ve
va
lu
e
an
d
se
n
si
ti
v
it
y
sc
or
es
fo
r
co
m
p
le
te
tu
m
or
,
tu
m
or
co
re
an
d
en
h
an
ci
n
g
re
gi
on
s
on
th
e
4-
la
b
el
te
st
in
g
d
at
as
et
fo
r
th
e
p
ar
ti
ci
p
at
ed
gr
ou
p
s
of
th
e
B
ra
T
S
C
h
al
le
n
ge
.
D
ic
e
P
os
it
iv
e
P
re
d
ic
ti
ve
V
al
u
e
S
en
si
ti
v
it
y
co
m
p
le
te
co
re
en
h
an
ci
n
g
co
m
p
le
te
co
re
en
h
an
ci
n
g
co
m
p
le
te
co
re
en
h
an
ci
n
g
N
ag
es
h
S
u
b
b
an
n
a
0.
75
(4
)
0.
70
(1
)
0.
43
(2
)
0.
69
(6
)
0.
75
(1
)
0.
41
(5
)
0.
90
(1
)
0.
69
(3
)
0.
57
(2
)
L
ia
n
g
Z
h
ao
0.
82
(1
)
0.
66
(2
)
0.
36
(7
)
0.
86
(1
)
0.
72
(3
)
0.
29
(8
)
0.
80
(6
)
0.
73
(2
)
0.
60
(1
)
D
ar
ko
Z
ik
ic
0.
75
(3
)
0.
47
(6
)
0.
41
(4
)
0.
79
(3
)
0.
72
(2
)
0.
46
(2
)
0.
79
(8
)
0.
44
(7
)
0.
44
(7
)
A
n
d
ac
H
am
am
ci
0.
72
(5
)
0.
57
(3
)
0.
43
(1
)
0.
66
(7
)
0.
51
(8
)
0.
46
(1
)
0.
86
(2
)
0.
81
(1
)
0.
51
(3
)
S
te
fa
n
B
au
er
0.
66
(7
)
0.
49
(5
)
0.
42
(3
)
0.
63
(8
)
0.
63
(4
)
0.
41
(4
)
0.
80
(7
)
0.
49
(6
)
0.
45
(6
)
B
jo
er
n
M
en
ze
0.
69
(6
)
0.
33
(7
)
0.
39
(6
)
0.
78
(4
)
0.
57
(6
)
0.
42
(3
)
0.
67
(9
)
0.
29
(8
)
0.
46
(5
)
R
ap
h
ae
l
M
ei
er
0.
65
(8
)
0.
51
(4
)
0.
39
(5
)
0.
62
(9
)
0.
56
(7
)
0.
37
(6
)
0.
81
(5
)
0.
59
(5
)
0.
47
(4
)
E
ze
q
u
ie
l
G
er
em
ia
0.
62
(9
)
0.
32
(8
)
0.
31
(8
)
0.
80
(2
)
0.
60
(5
)
0.
36
(7
)
0.
56
(1
0)
0.
28
(1
0)
0.
32
(8
)
In
es
N
je
h
0.
77
(2
)
0.
21
(9
)
0.
00
(1
0)
0.
77
(5
)
0.
22
(9
)
0.
00
(1
0)
0.
84
(3
)
0.
29
(9
)
0.
00
(1
0)
H
o
o-
C
h
an
g
S
h
in
0.
30
(1
0)
0.
17
(1
0)
0.
04
(9
)
0.
23
(1
0)
0.
12
(1
0)
0.
04
(9
)
0.
83
(4
)
0.
66
(4
)
0.
06
(9
)
65
T
ab
le
3.
5:
D
ic
e
ov
er
la
p
,
p
os
it
iv
e
p
re
d
ic
ti
ve
va
lu
e
an
d
se
n
si
ti
v
it
y
sc
or
es
fo
r
co
m
p
le
te
tu
m
or
,
tu
m
or
co
re
an
d
en
h
an
ci
n
g
re
gi
on
s
on
th
e
4-
la
b
el
tr
ai
n
in
g
d
at
as
et
fo
r
th
e
p
ar
ti
ci
p
at
ed
gr
ou
p
s
of
th
e
B
ra
T
S
C
h
al
le
n
ge
.
D
ic
e
P
os
it
iv
e
P
re
d
ic
ti
ve
V
al
u
e
S
en
si
ti
v
it
y
co
m
p
le
te
co
re
en
h
an
ci
n
g
co
m
p
le
te
co
re
en
h
an
ci
n
g
co
m
p
le
te
co
re
en
h
an
ci
n
g
S
ye
d
R
ez
a
0.
92
(1
)
0.
91
(2
)
0.
68
(1
)
0.
97
(1
)
0.
95
(1
)
0.
70
(1
)
0.
89
(5
)
0.
88
(2
)
0.
66
(1
)
D
ar
ko
Z
ik
ic
0.
92
(2
)
0.
93
(1
)
0.
63
(2
)
0.
86
(4
)
0.
92
(2
)
0.
63
(4
)
0.
98
(1
)
0.
94
(1
)
0.
64
(2
)
N
ic
k
T
u
st
is
on
0.
88
(3
)
0.
76
(3
)
0.
55
(3
)
0.
88
(2
)
0.
80
(6
)
0.
65
(3
)
0.
89
(4
)
0.
79
(4
)
0.
53
(3
)
L
ia
n
g
Z
h
ao
0.
86
(4
)
0.
75
(4
)
0.
55
(4
)
0.
88
(3
)
0.
86
(4
)
0.
65
(2
)
0.
86
(7
)
0.
72
(5
)
0.
50
(6
)
R
ap
h
ae
l
M
ei
er
0.
80
(6
)
0.
66
(6
)
0.
53
(5
)
0.
77
(8
)
0.
71
(8
)
0.
56
(7
)
0.
85
(8
)
0.
68
(7
)
0.
52
(4
)
A
n
d
ac
H
am
am
ci
0.
81
(5
)
0.
69
(5
)
0.
49
(8
)
0.
78
(7
)
0.
63
(9
)
0.
54
(8
)
0.
89
(3
)
0.
85
(3
)
0.
46
(8
)
N
ag
es
h
S
u
b
b
an
n
a
0.
78
(8
)
0.
66
(7
)
0.
46
(9
)
0.
66
(9
)
0.
87
(3
)
0.
62
(5
)
0.
97
(2
)
0.
56
(9
)
0.
40
(9
)
S
te
fa
n
B
au
er
0.
79
(7
)
0.
64
(8
)
0.
49
(7
)
0.
79
(5
)
0.
74
(7
)
0.
54
(9
)
0.
82
(9
)
0.
61
(8
)
0.
49
(7
)
T
h
om
as
T
ay
lo
r
0.
68
(9
)
0.
62
(9
)
0.
52
(6
)
0.
78
(6
)
0.
83
(5
)
0.
60
(6
)
0.
62
(1
0)
0.
53
(1
0)
0.
50
(5
)
H
o
o-
C
h
an
g
S
h
in
0.
46
(1
0)
0.
36
(1
0)
0.
35
(1
0)
0.
35
(1
0)
0.
27
(1
0)
0.
35
(1
0)
0.
86
(6
)
0.
69
(6
)
0.
39
(1
0)
66
3.5 Discussion and Conclusions
Originally we limited the scope of the “Tumor-cut” algorithm to the contrast en-
hanced gross tumor volumes, which corresponds to the tumor core of the high grade
tumors in Table 3.2. The comparison of the performance with the other partici-
pating algorithms shows that the “Tumor-cut” performs superior to others for the
segmentation of the tumor core of high grade glioma cases, whereas perform similar
for other categories, except edema segmentation of the low grade tumors, which is
usually not of interest in low grade gliomas.
For the 4-label challenge results given in 3.4, “Tumor-cut” algorithm performed
comparable to the state-of-the-art techniques participated in the challenge. Because,
the “Tumor-cut” method is not based on learning on the training dataset, the results
obtained for both training and testing datasets are similar as expected. However,
the low ranking in Table 3.5 is possibly due to the learning-based biased performance
evaluation of the other algorithms.
Disadvantages of the interactive segmentation algorithms in general can be noted
as: increased processing time and the possibility to miss some in case of multiple
tumors, difficulty in batch processing of patient databases and intra/inter operator
variability.
We observed that in one case only, we segmented an abnormal structure, which
was not labeled as tumor by the experts. Although, this resulted a zero overlap
score for the particular case, in fact, to allow user to choose what to segment is
an advantage of the semi-automatic approach. In general, the T2 results did not
provide useful information, as only a small portion of the tumors consist of the non-
enhancing region and the segmentation results were not accurate due to the low
contrast between tumor core and edema. The approach of “Tumor-cut” method
was to apply the original algorithm independently to each modality. A combined
algorithm that considers the multidimensional information from all available modal-
ities have the potential to improve the results obtained.
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Chapter 4
Potential Tumor Response
Criteria based on the Invariants of
the Finite Strain Tensor1
4.1 Tumor Follow-up
The work on developing a common language, in order to evaluate the therapy re-
sponses of the tumors in an objective and consistent manner, was accelerated after
mid 1970’s. For this purpose, the World Health Organization (WHO) criteria titled
”Reporting results of cancer treatment” which is published by World Health Orga-
nization (WHO) in 1979 [54] and by Miller et.al. in 1981 [55] were widely used as a
standard in the studies. WHO criteria proposes to calculate the total tumor load to
determine the treatment response by multiplying the maximum diameter in any of
the three orthogonal planes (axial, sagittal or coronal) and the maximum diameter
in the perpendicular plane for each tumor and summing up over measurable lesions
(2 dimensional). The measurement of the tumor load should be done at the begin-
ning of the treatment and with equal time interval follow-ups by the same method.
Whenever the accurate measurement in 2 dimensions is not possible, only the the
single longest diameter of the tumor would be reported. Treatment responses for
the measurable diseases are classified under 4 categories:
1The work presented in this chapter appeared in the European Society of Magnetic Resonance
in Medicine and Biology (ESMRMB) Conference, 2012.
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• Complete Response (CR): The disappearance of all known disease.
• Partial Response (PR): No new lesion, no progression of any lesion and at
least 50% decrease in total tumor load.
• Progressive Disease (PD): A 25% or more increase in the size of any measurable
lesions or the appearance of new lesions.
• No change (NC): No response or progression.
Complete and partial responses should be verified by a second measurement
following the observation. [47].
In 1990, after the publication of the application of WHO criteria on brain tumors
by Macdonald et.al., MacDonald criteria became a standart used on brain tumor
studies [10, 11].
However, summing up the multiplication of bidimensional measurements, needs
excessive workload and the results are error-prone and causes some problems about
the usage of the WHO criteria [56, 57, 58]:
1. The usage of the tumor size changes in response evaluation varies between
research groups.
2. The number of lesions and the minimum lesion sizes noted shows variations.
3. ”Progessive Disease (PD)” is defined on a single lesion by some groups, while
calculated on total tumor load by some other groups.
4. The technological development of the measurement devices (Computed To-
mography and Magnetic Resonance Imaging), causes confusions on how to
use 3-dimensional measurements on tumor response studies.
Addressing those problems, in the mid 1990’s, a study is initiated to develop a
new set of criteria by ”The European Organization for Research and Treatment of
Cancer (EORTC)”, ”The National Cancer Institute (NCI) of the United States”,
and ”The National Cancer Institute of Canada, Clinical Trials Group” and published
in the year 2000, under the name Response Evaluation Criteria in Solid Tumors
(RECIST) [59]. In this widely used RECIST tumor response criteria, the maximum
69
diameter of the tumor measured in any plan is used for tumor follow-up. Comparison
studies revealed that the overall results obtained by unidimensional measurements
of a single maximum diameter (RECIST) are equivalent to the bidimensional WHO
criteria [56, 59, 58, 60].
In this chapter, as well as the global criteria such as diameter and volume mea-
surements, the potential of the local criteria on assessment of the tumor evolution
is studied and explained in the following section.
4.2 Deformable Registration for Tumor Follow-
up
The first step in assessment of the tumor evolution between consecutive MR im-
ages of the patient locally and accurately is the alignment of the MR volumes by
a rigid registration. One of the state-of-the-art rigid alignment techniques such
as a normalized cross correlation-based registration could be applied (e.g. using
SPM toolbox Rigid Registration). However, for an intra-patient alignment prob-
lem, which involves registration of MR volumes of the same patient at different time
points (e.g. before and after therapy) with varying degrees of tumor tissue of highly
heterogeneous characteristics, an anatomic landmark-based rigid registration was
developed by Demir et.al. [61], which could be utilized in our pre-alignment phase.
In this study, “Block Matching” algorithm of the MedINRIA software is used for
rigid registration of the reference and follow-up contrast enhanced T1 MR volumes
of the tumor patient.
After the rigid alignment of the reference and follow-up volumes of the tumor
patient, a deformable registration is proposed to be used, to create a mapping
(A (x ) : Ω → Ω where Ω ∈ R3 is the domain of the image volume) between
the binary tumor volumes on both images obtained by the Tumor-cut segmentation
algorithm. Diffeomorphic Demons algorithm, which is one of the most accurate and
robust registration algorithms in the literature is used to create a deformation map
from the reference tumor to the follow-up tumor [1]. Diffeomorphic demons algo-
rithm, which is based on Thirion’s Demons algorithm [62], can be interpreted as an
optimization procedure in the space of displacement vectors. Deformable transfor-
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mation, which is defined by the displacement vectors (u : R3 → R3) for each voxel
on the image space (A (x ) = x + u ), is calculated by using the intensity based
forces obtained from the image. Following the construction of the displacement vec-
tors for each voxel, the resulting displacement field is regularized by using Gaussian
smoothing. Demons iterations can be summarized by the following:
1. Displacement field is initialized to s .
2. By using SSD (sum of square differences) the displacement field u between F
(reference) and M (moving image) is optimized by minimizing the norm:
Ecorr(u ) =|| F −M(s + u ) ||2 + || u ||2 (4.1)
where F denotes the referrence (static) volume and M is the moving volume.
3. Vector field is updated by: c ←− s + u
4. Vector field c is regularized by Gaussian smoothing: s ←− G(c )
The iterations 1-4 above is finalized when the update of the estimated vector
field lowers below a treshold. Although the Demons algorithm works efficiently,
it has some limitations in terms of similarity measures and transformation con-
straints. One of the improvements in the literature, addressing those problems, is
the “Diffeomorphic Demons” algorithm [1]. In diffeomorphic registration, not only
the intensity differences but also the transformation properties are considered, to
obtain a topology preserving transformation.
Mathematically, a diffeomorphism; is an invertable function which maps a differ-
entiable manifold to another. Both the function and its inverse are smooth functions,
which preserves the topology of the anatomical regions. Meanwhile, a one-to-one
and invertable mapping is obtained without foldings of the function. In order to as-
sure the diffeomorphism, the vector field is calculated in Lie space in Diffeomorphic
Demons algorithm [1]. When the transformations are summed basically, as in the
summation (+) operation given in the 3rd step above, the result is not guaranteed
to belong to the same space, for they do not form a vector space. Instead of using
a basic summation, if a composition (o) is done by using Lie group structure, the
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transformation estimated by the 3rd step given below would be preserved in the
vector space.
The iterations of the Diffeomorphic Demons algorithm can be summarized as
following:
1. Displacement field is initialized to s .
2. By using SSD (sum of square differences) the displacement field u between F
(reference) and M (moving image) is optimized by minimizing the norm:
Ecorr(u ) =|| F −M(s ◦ exp(u )) ||2 + || u ||2 (4.2)
where F denotes the referrence (static) volume and M is the moving volume.
3. Vector field is updated by: c ←− s ◦ exp(u )
4. Vector field c is regularized by Gaussian smoothing: s ←− G(c )
An example comparing the classical Demons algorithm and the Diffeomorphic
Demons algorithm is given in Figure 4.1. Here, F denotes the referrence (static)
volume and M is the moving volume. It can be seen that the topology of the
reference volume is preserved better by the Diffeomorphic Demons algorithm.
Figure 4.1: Comparison of the classical Demons and the Diffeomorphic Demons
algorithms.
In Figure 4.2, the same sample slice of the reference and follow-up contrast en-
hanced T1 images of a tumor patient are shown. Here, it can be seen that the volume
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and diameter of the tumor is decreased after the treatment. First, Diffeomorphic
Demons deformable registration algorithm is applied to register the reference and
follow-up contrast enhanced T1 weighted MR images of the brain tumor patients.
However, the results were not successful. Briefly, the displacement vector field ob-
tained by using the voxel intensity values of the reference and follow-up volumes
was not able to map the tumor volume before the therapy to the tumor volume
after the therapy. One of the possible reasons for this failure is thought to be the
effect of the deformation caused by the background and surrounding structures on
the deformation of the tumor region.
Figure 4.2: Left: Tumor of a patient on the reference scan before the therapy; Right:
The same tumor on the follow-up slice.
In order to solve the encountered problem of intensity based registration, the
tumors on both reference and follow-up volumes are segmented and then the Diffeo-
morphic Demons algorithm is applied to determine the deformation field between
the tumor surfaces. To segment the tumors on both volumes, Tumor-cut algorithm
described in detail in Chapter 2 and in [43] is applied. Contours of the tumor on
both reference and follow-up images are overlayed on a sample slice of the reference
MRI in Figure 4.3.
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Figure 4.3: Red: Contour of the tumor in reference scan. Blue: Contour of the
tumor in follow-up scan, overlayed on the reference MRI.
4.3 Deformation Gradient, Lagrange Strain Ten-
sor, and its Invariants
After obtaining the segmented binary tumor maps on both MR volumes, ”Diffeo-
morphic Demons” deformable registration algorithm is applied to estimate a smooth
deformation field between the reference and follow-up binary tumor volumes [1]. The
displacement field is defined as on each voxel of the moving (follow-up) volume map-
ping to the static (reference) volume: X = A (x ), x : denote the coordinates in
moving frame where, X are the coordinates in the constant volume. Deformation
field A (x ), can be written in terms of displacement field u (x ) as:
A (x ) = x + u (x ) (4.3)
To calculate the total deformation of the tumor, which is related to the amount
of shape change, tensors used in the field of continuum mechanics are used (e.g. see
[63]). The differential relation between the static and moving coordinate frames are
given as:
dX = F dx (4.4)
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where F is known as Jacobian, or the deformation gradient:
F =
∂A
∂x
(4.5)
F can be calculated by using the estimated displacement field:
F = I +∇xu (4.6)
In equation 4.6, I is the identity tensor, ∇xu is the gradient of the displacement
field.
The binary tumor volumes obtained by the Tumor-cut segmentation algorithm
are deformably registered, and a sample 2D slice of the resultant 3D displacement
field u is visualized on a reference MR slice in Figure 4.4. Inward direction of the
vector field on the reference MR image indicates the shrinkage of the tumor.
Figure 4.4: Vector field overlayed on a sample reference MR slice.
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After obtaining a deformation field between the tumors on the reference and
follow-up scans, the estimated 3D vector field can be further interpreted to calculate
a local response criteria. As an example, the determinant of the jacobian of the
displacement vector field, det(∇xu ), is calculated and visualized as a color map in
Figure 4.5.
Figure 4.5: Determinant of the jacobian of the 3D vector field visualized as a color
map on a sample slice.
By using F , the Left Green Deformation Tensor:
C = F TF (4.7)
and Lagrange Strain Tensor:
T =
1
2
[C − I ] (4.8)
can be defined [63]. To calculate a scalar map over a 2nd order tensor, the eigenvalue
and eigenvector equation can be used:
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T v = λv (4.9)
where v represents the eigenvector, and λ is the eigenvalue. Three eigenvalues can
be determined by solving the characteristic equation:
det(T − λI ) = −λ3 + λ2I1 − λI2 + I3 = 0 (4.10)
In the equation above, I1, I2, I3 are defined as the invariants of the tensor T and
can be calculated as:
I1(T ) = T · I = tr(T ) = T mm (4.11)
I2(T ) =
1
2
[(T · I )2 − (T · T T )] = 1
2
[(T mm)
2 − T mnT nm] (4.12)
I3(T ) = det(T ) (4.13)
where det is the determinant of the tensor, tr is the trace of the tensor, and the “·”
represents the inner product of two tensors.
The first invariant I1 is a measure of local volume change (< 0 shrinkage and
> 0 expansion), the second invariant I2 is a measure of the strain magnitude, and
the third invariant I3 can be interpreted as again a sort of measure for the local
volume change.
In order to quantify the amount of deformation between the tumors on the
reference and follow-up scans, the Lagrange Strain tensor T is calculated using
equation (4.8), and the tensor invariants I1, I2, I3 are determined by using equations
(4.11),(4.12),(4.13).
The evaluation studies of the proposed tensor invariants on synthetic and real
MR volumes is described in the next section.
4.4 Evaluation of the Tumor Response Criteria
4.4.1 Evaluation of the Tensor Invariants on the Synthetic
Volumes
For further interpretation of the tensor invariants, phantom studies are performed. 3
dimensional deformation fields are estimated, as described in Section 4.2, on spher-
ical and ellipsoidal volumes generated synthetically. Followed by the calculation of
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the Lagrange Strain tensor, tensor invariant I1, I2, I3 maps are calculated based
on this estimated 3D displacement field. The results are given below for various
phantoms:
(1) Expansion in a single dimension In order to investigate the
effect of the expansion in a single dimension, a spherical volume is mapped to an
ellipsoid which is expanded in only one dimension. A sample 2D slice is shown in
Figure 4.6, where blue ellipsoid represents the moving volume and white sphere is
the static volume. Mathematically, the generated phantoms are as following:
Static volume: {(x, y, z) : (x− 350)2 + (y − 350)2 + (z − 100)2 < 502}
Moving volume: {(x, y, z) : 0.5(x− 350)2 + (y − 350)2 + (z − 100)2 < 502}
Sample 2D slices of each tensor invariant maps are shown in Figure 4.7.
Figure 4.6: Blue contour: Ellipsoidal moving volume. White: Spherical static vol-
ume. Displacement vectors are from ellipsoid to sphere.
Figure 4.7: A sample slice of the tensor invariant I1,I2,I3 maps between the two
volumes in Figure 4.6.
(2) Spherical expansion To investigate the effect of the spherical ex-
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pansion, two co-centric spheres with different radius are used. A sample 2D slice is
shown in Figure 4.8, where the blue sphere is deformed to the white one. Mathe-
matically, the spheres are generated by:
Static volume: {(x, y, z) : (x− 350)2 + (y − 350)2 + (z − 100)2 < 802}
Moving volume: {(x, y, z) : (x− 350)2 + (y − 350)2 + (z − 100)2 < 502}
Sample 2D slices of each tensor invariant maps are shown in Figure 4.9.
Figure 4.8: Blue contour: Small spherical moving volume. White: Larger spherical
static volume. Displacement vectors are from larger to the small sphere.
Figure 4.9: A sample slice of the tensor invariant I1,I2,I3 maps between the two
volumes in Figure 4.8.
(3) Translation in a single direction To investigate the effect of the
translation in a single direction, two spheres at the same size but with translated
center points are used. A sample 2D slice is shown in Figure 4.10, where the blue
sphere is obtained by translating the white one.
Mathematically, the generated phantoms are as following:
Static volume: {(x, y, z) : (x− 350)2 + (y − 350)2 + (z − 100)2 < 502}
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Moving volume: {(x, y, z) : (x− 320)2 + (y − 350)2 + (z − 100)2 < 502}
Sample 2D slices of each tensor invariant maps are shown in Figure 4.11.
Figure 4.10: Blue contour: Original spherical static volume. White: Moving volume
generated by translating the original sphere. Displacement vectors are from white
sphere to the blue one.
Figure 4.11: A sample slice of the tensor invariant I1,I2,I3 maps between the two
volumes in Figure 4.10.
To evaluate the usage of the tensor invariants I1,I2,I3 on quantifying the shape
changes, shrinkage in a single direction and translation in a single direction are
applied with different amounts and the results are mapped seperately. Using those
tensor invariant maps, scalar measures are obtained and listed in Table 4.1. In this
table, the first three rows are the volumes of the moving and static phantoms, and
the percentage of the volume change. The integrals over the whole displacement
domain for the invariants are given in the next three rows, where the last three
rows are the coefficient of variations for each invariant given as the ratio of the
standart deviation to the average over the domain. Considering the expansion of
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the sphere to three different ellipsoids, given in the first 3 columns of the table, the
integrals and variation of coefficients of the tensor invariants are correlated with the
volume changes. At the last 2 columns, instead of changing the volume, translation
is applied by different amounts. The coefficient of variations (especially CV I3)
shows high variation, which is not observed in volume changes. Evaluation studies
done on synthetic phantoms reveal the potential usage of the tensor invariants for
assessment of the tumor changes.
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4.4.2 Evaluation of the Tensor Invariants on Clinical Cases
Evaluation studies of the tensor invariant measures, which are tested on synthetic
phantoms, are performed on radiotherapy patients. The contrast enhanced T1
weighted MR volumes of 16 patients (Glioblastoma Multiforme or Acoustic Neu-
roma patients) acquired before and after the therapy performed in Anadolu Health
Center (ASM) are included. Firstly the MRI volumes acquired after the therapy are
aligned with the volumes before the therapy using a rigid transformation (6 degrees
of freedom). For both volumes, tumor core and the necrotic regions within the tu-
mor are segmented using the Tumor-cut method described in detail in Chapter 2
and in [43]. The dense displacement field between the two tumor maps is esti-
mated by using the Diffeomorphic Demons algorithm [1]. Corresponding Lagrange
Strain tensors and the 3D map of the tensor invariants I1,I2,I3 are calculated for
the estimated displacement field. For each patient, calculated change measures are
given in Table 4.2. Furthermore, tensor invariants computed on the sample data in
Figure 4.12 are given in Figure 4.13 and 4.14.
Figure 4.12: Sample MR slices of a patient before (left) and after (right) the treat-
ment.
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Figure 4.13: Tensor invariants calculated for the patient in Figure 4.12.
Figure 4.14: Visualization of the calculated tensor invariants on the MR images
acquired before (left column) and after (right column) the therapy.
4.5 Clinical Usability Experiments
Contrast enhanced T1 weighted spoiled gradient echo volumes acquired before and
after the radiosurgery treatment of 16 patients; 4 with Glioblastoma Multiforme
(GBM) and 12 with Acoustic Neuroma were included in the study, retrospectively.
In order to evaluate the potential clinical usage of the proposed method, for the
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cases given in Table 4.2 clinical and radiological assessments reported before and
after the treatment are scored by the convention defined in Table 4.3 and tabulated
in Table 4.4.
Table 4.3: Scoring convention used to quantify clinical and radiological outcomes.
Convention For Scoring Convention For Scoring
Clinical Outcome Radiological Assesment
-1 : Reduced Symptoms -1 : Reduction in size
0 : Stability 0 : Unchanged
+1 : Increased Symptoms +1 : Increased in size
The discriminative value of each of the measures: volume change, maximum di-
ameter change, integrals and coefficient of variations of tensor invariants I1,I2,I3 is
determined by Kruskal-Wallis test and the p values are given in Table 4.5. The vari-
ance analysis graphs for the most discriminative parameters coefficient of variation
of I2 and integral of I3 are given in Figure 4.15 and 4.16.
Figure 4.15: Distribution of the coefficient of variation of I2 for three clinical out-
comes (p = 0.05).
Clinical outcomes are visualized on coefficient of variation of I2 v.s. integral of I3
plot in Figure 4.17. As seen on the graph, coefficient of variation of I2 performs bet-
ter in identifying clinical improvement whereas integral of I3 is more discriminative
in disease progression. Also a possible linear classification is proposed by the red
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Table 4.4: Clinical and radiological assessments reported before and after the treat-
ment for the cases given in Table 4.2.
Patient Diagnose Clinical Radiology Radiology
Id Outcome Volume Change Necrotic Volume Change
1 Acoustic neuroma 0 0 +1
2 Acoustic neuroma -1 0 +1
3 Acoustic neuroma 0 +1 +1
4 GBM -1 +1 0
5 Acoustic neuroma -1 0 0
6 Acoustic neuroma 0 0 +1
7 GBM +1 +1 0
8 Acoustic neuroma 0 0 +1
9 Acoustic neuroma -1 0 +1
10 Acoustic neuroma -1 0 +1
11 GBM +1 +1 0
12 GBM 0 -1 0
13 Acoustic neuroma 0 -1 +1
14 Acoustic neuroma -1 0 +1
15 Acoustic neuroma -1 -1 +1
16 Acoustic neuroma -1 -1 +1
Figure 4.16: Distribution of the integral of I3 for three clinical outcomes (p = 0.10).
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Table 4.5: P values obtained by comparing the clinical outcomes to the calculated
measures and radiological assessments by Kruskal-Wallis test.
Radiological Maximum Volume C.V. C.V. C.V. Integral Integral Integral
Assessment Diameter I1 I2 I3 I1 I2 I3
p 0.12 0.34 0.33 0.54 0.05 1.00 0.44 0.54 0.10
and blue lines on the same plot, which provides the results of the proposed method
referred in Table 4.18 .
Figure 4.17: Clinical outcomes plotted on coefficient of variation of I2 v.s. integral
of I3 graph.
Clinical outcomes are compared to the results obtained by the proposed method
and the radiological assessment in Table 4.18. In disease progression and stabil-
ity cases, both the method and the radiological assessment provides similar results,
whereas it can be seen that the proposed method performs better in clinical im-
provement.
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Figure 4.18: Comparison of the clinical outcomes with the calculated measures and
radiological assessments.
4.6 Conclusions
For clinically unchanged and worsened cases, both radiological assessment and the
proposed method resulted in the same prediction performance, whereas consider-
ing the best linear classifier applicable, the method outperformed the basic global
measurements used in the radiological assessment for those cases with clinical im-
provement.
The volume change, show less importance in explaining the clinical outcome,
whereas the variation of the second invariant which is a measure of the strain mag-
nitude and the integral of the third invariant which quantifies the local volume
change of the deformation plays a more important role.
The results presented show that the analysis of the deformation fields of tumor
changes using methods of solid mechanics might provide results that are more cor-
related to the clinical outcomes of the therapy than considering only the volume or
largest diameter measurements.
The results need further validation on larger datasets and the effect of the reg-
ularization while obtaining the deformation field on the results should be consid-
ered.
89
Chapter 5
Registration of Brain Tumor
Images using Hyper-elastic
Regularization1
5.1 Introduction
Registration of pre-therapy and post-therapy brain volumes with tumors is an impor-
tant task to be able to track the changes between two instances in order to assess the
progression of the tumor and the treatment response. The first step is a rigid/affine
registration between the two volumes. Although this is a challenging problem due
to the changes caused by the tumor, various approaches on the problem reported
successful results in the literature [61, 64, 65]. The total deformation caused by the
tumor growth can be taught as the combination of infiltration to the healthy tissue
and mass effect components. Our aim in this work is to separate the mass effect and
infiltration components, so that, malignancy and the reversibility of the destruction
can be determined. The healthy brain tissue in one of the images can be warped
onto the other ignoring the tumor tissue regions, as the latter may contain uncer-
tainty due to highly complex tumor growth and therapy processes. Hence, the idea
proposed in this thesis of matching only the healthy tissues in baseline and follow-up
tumor images will provide an estimation of the intracranial pressure caused by the
1Preliminary part of this work presented in this chapter appeared in the Computational Biome-
chanics for Medicine, pp. 101-114, Springer, 2013 and the current version is in preparation for
submission as a journal article.
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tumor growth plus the mass effect (see Figure 5.1).
Figure 5.1: Schematic explanation of the idea proposed in the thesis to separate the
tumor growth and the mass effect.
A similar problem arises in deformable registration of the brain with tumors to
a healthy population atlas. The main difference to the intra-subject registration
problem is that the deformation also includes inter-subject variations. Hence, a
general strategy to solve this problem is to iterate the forward model by simulating
the tumor growth on the atlas and refining the parameters of the simulation model
by comparing it to the tumor image [66]. This requires strong models, which rely
on realistic models of tumor growth and deformations due to the mass effect [66,
67, 68, 69]. The main problem with those approaches is that the growth of the
tumor is mostly affected by the uncontrolled parameters such as treatment and
requires sophisticated tumor growth models even without treatment. In ”Geometric
Metamorphosis” paper, Niethammer et.al, proposed an interesting approach to the
problem using a weak model by separating the foreground, hence the tumor growth,
and the background changes [70].
For the problem of intra-subject registration, our approach is based on the as-
sumption that the deformations except around the tumor volume are caused by the
mass effect of the tumor, hence obey the bio-mechanical rules. This is different from
the atlas matching problem, which includes also inter-subject variations between the
images. Sample baseline and follow-up MRI slices are shown in Figs. 5.2 and 5.3.
Deformation of the ventricles and sulci due to the mass effect of the growing tumor
can be clearly observed on the right hemisphere of the subject (denoted by ”R” in
the figures). Although, a mapping of the tumor tissue between the baseline and
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Figure 5.2: A sample axial slice from baseline (on the right) and follow-up (on the
left) MRI.
Figure 5.3: A sample sagittal slice from baseline (on the right) and follow-up (on
the left) MRI.
the follow-up is not well defined due to the uncertain growth pattern and therapy
effects, a mapping between the healthy tissues can be estimated. Therefore, our
aim is to find a mapping between the healthy tissues of the brains, which obeys the
nonlinear elastic finite deformation models.
The results of the experimental studies on animals suggest to model the brain
with a homogeneous hyper-viscoelastic non-isotropic material [71]. In the image
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analysis literature, simplified hyper-elastic models are used: Neo-Hookean [72], Og-
den type [73, 74], Saint-Venant Kirchhoff model [75], linear viscoelastic type [68].
In their work, comparing viscoelastic, hyper-elastic and linear elastic models on
brain simulations, Wittek et. al. reports no significant difference on the results
obtained [76]. In ”Nonlinear Elastic Registration with Unbiased Regularization in
Three Dimensions”, Saint-Venant Kirchhoff model was used as a regularizer in the
registration of serial magnetic resonance images [75].
Our novel contributions in this chapter of the thesis are: (i) Matching healthy
tissue to healthy tissue of the brain using a dedicated image data term; (ii) Using
the hyper-elastic Neo-Hookean strain energy density as a regularizer in deformable
registration framework; (iii) Derivation of displacement field update equations based
on the Neo-Hookean model using Euler-Lagrange framework.
5.2 Background
Linear theories of solid mechanics are highly developed and are in a satisfactory
state of completion. In the theory of linear elasticity, the stress and strain are
related linearly by the Hooke’s Law:
σ = c : ε (5.1)
where σ is the Cauchy stress tensor, ε is the small strain tensor and c is the
fourth-order elasticity tensor that contains the material properties. However, this
linear model is only valid for infinitesimal or small strains. One of the simplest
nonlinear theory to model huge, reversible, shape changes is Hyper-elasticity, which
is used to model rubber and foams.
The mechanical properties of a hyper-elastic material are characterized com-
pletely by a scalar strain-energy density function W. Specifying the strain energy
density W as a function of the deformation gradient F : W = W (F ) ensures that
the material is perfectly elastic. The general form of the strain energy density, W ,
is guided by experiment [63].
Let us define the displacement field from the un-deformed to deformed config-
uration as u : Ω −→ R3 where Ω ∈ R3. In addition to the strain energy density
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W = W (x ,∇u ), let f = f(x ,u (x )) denote the external energy, then the equilib-
rium configurations can be determined as the minima of the total energy functional:
E(u ) =
∫
Ω
W (x ,∇u )dx −
∫
Ω
f(x ,u )dx (5.2)
The Euler-Lagrange system associated with the functional E, which is a necessary
condition for a minimizer of the total energy given in Eqn. 5.2, is precisely the
equilibrium equation:
div(
∂W
∂F
(x ,∇u (x ))) + ∂f
∂u
(x ,u (x )) = 0 (5.3)
where Fij = σij +
∂ui
∂xj
is the deformation gradient and ∂W
∂F
T
is called the First
Piola-Kirchhoff tensor in the mechanics literature [77].
Commonly, constitutive hyper-elastic strain energy density models are based on
principal strains λi, or invariants of the stretch tensor Ii, defined as:
I1 = λ
2
1 + λ
2
2 + λ
2
3
I2 = λ
2
1λ
2
2 + λ
2
2λ
2
3 + λ
2
1λ
2
3
I3 = λ
2
1λ
2
2λ
2
3 (5.4)
With the incompressibility assumption for the material, I3 is taken to be constant
and equal to 1.0 and does not contribute to the strain energy. One of the most simple
models is the Neo-Hookean model, which is given as:
WNH = C(I1 − 3) (5.5)
Another model that has been extensively utilized in studies of elastomer deformation
is the Mooney-Rivlin model, given as:
WMR = C1(I1 − 3) + C2(I2 − 3) (5.6)
A more general form in terms of principal stretches is the Ogden model, given
as:
WO =
∑
n
µn
αn
(λαn1 + λ
αn
2 + λ
αn
3 − 3) (5.7)
where n is the degree of the model and µn and αn are the model parameters.
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Note that the Neo-Hookean model results from Eqn. 5.7 by setting n = 1 and
α1 = 2, whereas Mooney-Rivlin model can be obtained by setting n = 2, α1 = 2,
α2 = −2.
Although rubber elastic materials are generally considered to be incompress-
ible, including compressibility increases accuracy, improves models where the bulk
response is important and helps to avoid numerical problems inherent in incom-
pressibility assumption. Compressible forms of the strain energy function W are
developed in one of two ways. Both begin by removing the incompressibility restric-
tion that J = 1 where J =
√
I3. Decoupling approach assumes the strain energy
is a separable function of a deviatoric strain (distortional) energy and a hydrostatic
strain (volumetric) energy dealing with the volume change, as follows:
W = WD(I¯1, I¯2) +WH(J) (5.8)
where I¯1 and I¯2 are invariants of the deviatoric stretch tensor, I¯1 = J
−2/3I1, I¯2 =
J−4/3I2. Corresponding decoupled representations for hyper-elastic models can be
reformulated by replacing λi and Ii by the modified quantities λ¯i and I¯i, and adding
a suitable volumetric response function. For example, the decoupled strain-energy
function for the Mooney-Rivlin model has the form:
WMR(I¯1, I¯2, J) = C1(I¯1 − 3) + C2(I¯2 − 3) +WV OL(J) (5.9)
where WV OL can be selected as a penalty of the deviation of J from unity. Other
compressible formulations append a bulk strain energy term to an existing strain
energy form, as follows:
W = Wa(I1, I2, J) +Wb(J) (5.10)
Here, both Wa and Wb terms contain contributions due to the volume change. As an
example, the coupled form of the compressible Mooney-Rivlin model may be given
as:
WMR(I1, I2, J) = C1(I1 − 3) + C2(I2 − 3)− dlnJ + c(J − 1)2 (5.11)
where c is a material constant and d defines a parameter with certain restrictions.
Another example is the coupled form of the compressible neo-Hookean model given
by:
WNH(I1, J) =
c1
β
(J−2β − 1) + c1(I1 − 3) (5.12)
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with the constants c1 = µ/2 and β = ν/(1− 2ν). The material parameters µ and ν
denote the shear modulus and Poisson’s ratio, respectively [78, 79].
5.3 Methods
In deformable registration, the problem is to find the displacement field u from the
volume R to T, which minimizes the given functional:
u ∗ = arg min
u
∫
Ω
f(R(x ), T (x + u (x ))) + αW (x ,∇u )dx (5.13)
where f is the external energy density term calculated as a similarity measure be-
tween the reference (R) and target (T) volumes and α is the weighting parameter of
the regularizer term W . Let R(x ) and T (x ) denote the brain tissue maps (White
Matter + Gray Matter + Tumor) of reference (undeformed) and target (deformed)
volumes, respectively. The mechanical properties of white matter and gray matter
are assumed to be similar.
In this section, first, the energy forms for both image and regularizer terms that
are used in this study are introduced and corresponding Euler-Lagrange conditions
are derived. Then, details of the implementation of deformable registration is given.
5.3.1 Image Term for Matching the Boundaries of the Bod-
ies
A solution that matches the outside surfaces of the two bodies requires all the
displacements from the surface of the reference body (fixed body) to point the surface
of the target body (moving body). Therefore, an energy term, which penalizes the
distance from the surface of the reference body to the surface of the target can be
used for this purpose. Note that, displacement vectors can still move on the target
surface freely. This is ensured by the following energy term:
fB(x ,u (x )) = χ∂R(x )D∂T (x + u (x )) (5.14)
where χ∂R is the indicator function of the boundary of the reference body, having
the value of 1 for the points on the boundary and 0 elsewhere. D∂T is the distance
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to the boundary of the target body. By defining the distance function from a point
x to a set S ∈ Ω as:
d(x , S) = inf{‖x − y ‖2 : y ∈ S} (5.15)
and the signed distance function as:
φS(x ) =
 d(x , S) if x ∈ SC−d(x , SC) if x ∈ S (5.16)
The integrand of the total external energy functional can be written as:
fB(x ,u (x )) = δ0(φR(x )) · φT (x + u (x ))2 (5.17)
Here, squared distance is used to assure the continuity of the derivative at the
boundary while equally penalizing negative and positive distances. To derive the
Euler-Lagrange condition for this energy term, the derivative of the functional in
Eq. 5.17 is written as:
∂
∂u
fB(x ,u (x )) = δ0(φR(x )) · 2φT (x + u (x ))∇x+u(x)φT (x + u (x )). (5.18)
5.3.2 Hyper-elastic Regularizer
For simplicity, assuming a nonlinear hyper-elastic model in a decoupled Ogden form
as in [74]:
W =
2µ
α2
(λ¯1
α
+ λ¯2
α
+ λ¯3
α − 3) + 1
D1
(J − 1)2 (5.19)
where principal strains λ¯i = λi/J
1/3, λi = e
1/2
i , ei’s are eigenvalues of B = F F
T , J
is the determinant of the deformation J = det(F ) and deformation gradient tensor
Fij =
∂ui
∂xj
+ δij. In [71], α parameter of the model for the brain tissue is determined
as α = −4.7. For simplicity, in this work α = 2 is used, which is known as the
Neo-Hookean model. By replacing Tr(B) = λ21 + λ
2
2 + λ
2
3, the strain energy density
function becomes:
W =
µ
2
(
Tr(B)
J2/3
− 3) + 1
D1
(J − 1)2 (5.20)
The Euler-Lagrange condition on the displacement field u for minimizing the
given strain energy functional in terms of the trace and determinant is given by:
∂W
∂ui
−
∑
j
∂
∂xj
∂W
∂(∂ui/∂xj)
= 0 (5.21)
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The first term drops, as the energy density functional W is not dependent on the
u but its derivatives. The derivative with respect to ∂ui/∂xj is identical to the
derivative with respect to Fij, therefore, rewriting Eq. 5.21 results in:∑
j
∂
∂xj
∂W
∂Fij
= 0 (5.22)
The derivative ∂W
∂Fij
, which is also known as the 1st Piola-Kirchhoff tensor in me-
chanics literature, is obtained after a set of manipulations as follows (see Appendix
B):
− µ
J2/3
∑
j
(
∂F
∂xj
)ij +
2µ
3J2/3
∑
j
FijTr(F
−1∂F
∂xj
)
−(µTr(B )
3J2/3
− 2J(J − 1)
D1
)
∑
j
(F −1
∂F
∂xj
F −1)ji
−(2µTr(B )
9J2/3
+
2J(2J − 1)
D1
)
∑
j
(F −1)jiTr(F −1
∂F
∂xj
)
+
2µ
3J2/3
∑
j
(F −1)jiTr(
∂F
∂xj
F T ) = 0
(5.23)
In some cases, for the volumetric part of the strain energy, instead of (J − 1)2
above, the following form is used:
Wvol =
K
2
(lnJ)2 (5.24)
Similarly, the derivatives ∂W
∂Fij
, for this term can be derived (see Appendix C):
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
(F −1)jiTr[F −1
∂F
∂xj
]
−KlnJ
∑
j
(F −1
∂F
∂xj
F −1)ji (5.25)
5.3.3 Log-Barrier Method
At each iteration, inverse of the deformation F is computed, which requires the
determinant of the deformation to be non-zero. Furthermore, to avoid foldings at
the final result, the determinant of the deformation is needed to be positive at each
point. To assure both, an inequality constraint J > 0 can be imposed by using the
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log-barrier method, which contributes to the energy functional as:
W = −λlnJ (5.26)
where J is the determinant of the deformation F . For J is a function of F , similar
to the incompressibility term of the hyperelastic regularizer, the corresponding term
of the Euler-Lagrange condition can be calculated as (see Appendix D):
−
∑
j
∂
∂xj
∂W
∂Fij
= λ
∑
j
(F −1
∂F
∂xj
F −1)ji
5.3.4 Implementation Details
In the implementation, the δ(·) function is approximated as the derivative of a
regularized Heaviside function as in [26] as:
H(z) =
1
2
(1 +
2
pi
arctan(
z
ε
))
δ0(z) =
∂
∂z
H(z) =
1
piε
1
1 + ( z
ε
)2
(5.27)
Although the squared distance given in Equation 5.17 is useful to avoid oscil-
lations around the boundary due to the zero value near the boundary, at large
distances, the derivative is increasing with the distance, which causes uncontrolled
update steps and instabilities. To overcome those problems, the Huber function is
employed in the image term, which is given in [80] as:
ρk(z) =
 z
2
2
if |z| <= k
k|z| − k2
2
otherwise
(5.28)
That is this function incorporates the absolute value for farther distances, deter-
mined by a threshold “k”. A multi-resolution approach is implemented to increase
the convergence speed. Volumes are down-sampled using trilinear interpolation and
the obtained displacement field is interpolated to the higher resolution at the end
of each stage.
The update equation for the displacement field u is obtained by the steepest
descent method as:
∂u
∂t
= −(Eq.5.18 + Eq.5.23) (5.29)
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If the maximum change due to the regularizer is greater than 1, the update of the
displacement ∇uW , is normalized by dividing to the maximum update over the
image grid:
∇uW =
 ∇uWmax(∇uW ) if ∇uW > 1∇uW otherwise (5.30)
Scaling of the strain energy density function of the regularizer term is arbitrary.
Therefore, instead of having two independent parameters µ and D1 for the energy
functional in Eq. 5.20, the algorithm is affected mainly by the ratio µ
1/D1
= µD1.
The effect of a µD1 at a higher limit is shown on the sub-figure at the center
of Fig. 5.5, which corresponds to the first term in Eq. 5.20, whereas, the effect of
a zero µD1 is shown on the right sub-figure of Fig. 5.5, which corresponds to the
second term. In this work, our aim is to estimate the cause (tumor deformation)
by observing the result (displacement at the boundaries). Therefore, we assure the
reversibility by enforcing a highly incompressible behavior to prevent the energy to
be stored in the material, which we can not observe by MRI. This is achieved by
penalizing the local volume changes more by setting a low µD1. We also assume
that the total volume increase of the brain parenchyma is mostly caused by the
increase of the tumor volume. Therefore, by setting the tumor region as a hole
for the regularizer, which does not contribute to the external energy, and using
an incompressible strain energy density, the observed local volume changes at the
boundaries of the parenchyma are carried to the tumor area. We also note that, by
decreasing the µ, the dependence of the strain energy density to the model parameter
α in Eq. 5.19 is decreased, which strengthen our simplification approach of using
Neo-Hookean model (α = 2) instead of Ogden form with α = −4.7.
Starting with an initial time step δt for the regularizer, the value is halved if the
strain energy is not decreased by updating the displacement field.
The first derivatives are calculated by using central difference finite differencing
scheme as:
Vx(x, y, z) =
V (x+ h, y, z)− V (x− h, y, z)
2h
(5.31)
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The derivative ∂F
∂xj
is given by the following matrix:
∂F
∂xj
=

∂2u1
∂x1∂xj
∂2u1
∂x2∂xj
∂2u1
∂x3∂xj
∂2u2
∂x1∂xj
∂2u2
∂x2∂xj
∂2u2
∂x3∂xj
∂2u3
∂x1∂xj
∂2u3
∂x2∂xj
∂2u3
∂x3∂xj

Its components are calculated by second order finite difference discretization as:
Vxx(x, y, z) =
V (x− h, y, z)− 2V (x, y, z) + V (x+ h, y, z)
h2
Vxy(x, y, z)=
V (x+h, y+h, z)−V (x+h, y−h, z)−V (x−h, y+h, z)+V (x−h, y−h, z)
4h2
(5.32)
Other derivative components are calculated similarly.
At the boundaries Neumann boundary conditions, which sets a zero normal
derivative at the boundary, are used. To impose Neumann condition, the first
derivative is set to zero if any of the V (x + h, y, z) or V (x − h, y, z) in Eqn. 5.31
is missing (out of the volume). Note that, this also satisfies the normality to the
boundary. Let’s assume the value at the positive x direction is out of the volume.
By setting:
Vx(x, y, z) =
V (x+ h, y, z)− V (x− h, y, z)
2h
= 0 (5.33)
The missing value that satisfies zero normal boundary can be estimated by replicat-
ing the value inside to the outside as:
V (x+ h, y, z) = V (x− h, y, z) (5.34)
By this substitution, the second derivative at the boundary can be written as below:
Vxx(x, y, z) = 2
V (x− h, y, z)− V (x, y, z)
h2
(5.35)
Using a similar approach of substituting the missing terms is applied for calculating
the derivatives in other directions (i.e. Vy(x, y, z), Vz(x, y, z)) and the cross terms
of the second derivatives (i.e.Vxy(x, y, z)), at the boundaries.
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5.4 Experiments and Results
5.4.1 Regularizer Test
To test the regularizer initially, the algorithm is run on 10x10x10 mask on a 20x20x20
lattice with a single constant displacement vector (0.0001,0.0001,0.0) and zero bound-
ary conditions. The central xy-plane of the input and the result obtained with
µ = 0.8 and D1 = 1.0 is given in Fig. 5.4 with a closer look at Fig. 5.5. The effect
of setting the parameters of the model at the lower and higher limits is shown on
the middle and the right sub-figures of Fig. 5.5. Although, incompressibility is a
necessity for our problem as discussed in the method, setting a non-zero value to µ
helps to increase the stability of the solution.
Figure 5.4: Left: Input phantom for the regularizer test. Right: Output of the
regularizer test.
5.4.2 Experiments on FEBIO Simulations
In order to validate the proposed methodology of estimating the displacement field
inside the object, given the initial and final contours, simulation studies are per-
formed. FEBIO software, which is a nonlinear implicit finite element (FE) software,
is used for simulation studies [81]. A constant force is applied to a cubic solid object.
We used Mooney-Rivlin model, given below, with c2 = 0 to obtain an uncoupled
Neo-Hookean model.
W (λ1, λ2, λ3, J) = c1(I¯1 − 3) + c2(I¯2 − 3) + K
2
(lnJ)2 (5.36)
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Figure 5.5: Left: A closer view of the output of the regularizer test on phantom in
Figure 5.4. Middle: The result obtained on phantom by increasing µ in the strain
energy density model in Eq. 5.20. Right: The result obtained on phantom by setting
the µ as zero in the strain energy density model in Eq. 5.20.
Other material parameters are assigned as; c1 = 0.1 and K = 1.0. The same model
is implemented and the displacement field is estimated by the method proposed in
this chapter using the known initial and final states of the object. Simulated and
estimated displacement fields are shown in Figure 5.6.
Figure 5.6: The finite element simulation result obtained for the neo-hookean box,
on the left. Estimated displacement field for the same scenario by our method, on
the right.
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5.4.3 Experiments on MRI Brain Tumor Followup Volumes
The Data
MR images of a brain tumor patient (Glioblastoma Multiforme), obtained by 1.5T
MRI scanner at high resolution (≈ 0.5x0.5x1.0 mm) contiguous axial T1 weighted
3D SPGR (TE/TR = 3.16s/8.17s, FA=25deg) sequence acquired after IV injection
of 10cc 0.5M Multihance Gd, is used for validation study. The sample slices of the
baseline and the follow-up volume, obtained 35 days after, are given in Fig. 5.2 and
5.3.
Preprocessing MRI Volumes
Statistical Parametric Mapping (SPM8) software 2, distributed by Wellcome Trust
Centre for Neuroimaging, London, which gives accurate results in brain volumes
with tumors, is used for standard operations such as: rigid registration, brain tissue
segmentation and smoothing. Specifically, the following preprocessing operations
are applied to the data before the execution of the deformable registration:
• Follow-up volume is rigidly registered to the baseline volume using ”co-register”
function of SPM8.
• White matter (WM) and gray matter (GM) segmentations (P > 0.5) are
obtained for both volumes using SPM8.
• Tumors in both volumes are segmented using the Tumor-cut algorithm [53].
• For each of the volumes, Tumor, WM and GM segmentations are combined
using: ΩTumor ∪ ΩWM ∪ ΩGM .
• Each combined binary volume is smoothed by the ”smooth” function of the
SPM8 with a Gaussian kernel having 8x8x8mm full width at half maximum.
• Finally, binary maps are converted to isotropic voxels (1× 1× 1mm).
2http://www.fil.ion.ucl.ac.uk/spm/
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Results
After executing the proposed deformable registration algorithm proposed in this the-
sis on the MRI data of the patient, sample slices showing the resulting displacement
field, obtained on tumor patient data, are shown in Fig. 5.7. Intense displacement
on the hemisphere with tumor, due to the mass effect, can be observed. At the
bottom of the sub-figure on the right, displacement of the sulci due to the increased
cerebrospinal fluid (CSF) pressure can be seen. Also, the increase in the CSF pres-
sure results in slight displacements at the ventricles of the healthy hemisphere, on
the top. Displacement field, overlayed on a sample axial slice of the reference MRI
Figure 5.7: Sample slices of the result obtained on tumor patient data in 3x3x3mm
voxel size. Binarized brain tissue of the reference volume is labeled in white color,
the blue contour indicates the boundary of the target volume, and the displacement
field is indicated with arrows in red.
in high resolution, is given in Fig. 5.8. The mass effect around the tumor is clearly
observed. A closer look to the ventricle at the hemisphere without tumor depicts the
displacement due to the expansion of the ventricle. When we focus on the displace-
ment around the tumor as in Fig. 5.9, the displacement caused by the mass-effect
(at the top) and the tumor growth (on the right) can be observed. The vectors
at the the bottom-left of the tumor explains the local shrinkage of the tumor as a
tissue displacement.
5.5 Discussion and Conclusions
A method to register the brain tissues in baseline and follow-up MRI volumes using
hyper-elastic deformation models is presented. Implementations on synthetic and
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Figure 5.8: Displacement field (in red) overlayed on a sample MRI slice of the
reference volume, with the boundary of the target volume indicated with the blue
contour. A closer look to the ventricle of the hemisphere without tumor.
patient data, with only minimal user interaction, provide promising results, which
might have relevant use in clinical problems. Publicly available state-of-the-art algo-
rithms for the rigid registration and tissue/tumor segmentation are able to provide
highly accurate outputs, which are necessary initializations in order to obtain an
accurate displacement field. Accuracy of the method could be increased by improv-
ing the data term, such as by adding vessel correspondences or manual landmarks.
Furthermore, although in this thesis, we utilized a measure based on distances be-
tween pre- and post- tumor surfaces as the data (image) term, a direct utilization of
image intensity-based measures such as SSD, would be a straightforward extension
on the data term part of our method.
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Figure 5.9: A closer look to the tumor where the baseline tumor volume is labeled
with white color, the follow-up tumor boundary is indicated with blue contour and
the displacement field is overlayed with red arrows.
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Chapter 6
Summary and Discussion
Advanced image analysis techniques are involved in different stages of both the ra-
diotherapy treatment and follow-up of the brain tumors. Computational methods
used in radiation therapy usually involve intra/inter patient registration, segmen-
tation and tumor growth modeling, whereas, tumor follow-up involves intra/inter
patient and longitudinal registration, segmentation and change quantification steps.
In this thesis, image analysis techniques are developed for planning the image
guided radiotherapy and follow-up of the treatment responses. Three main parts
of the thesis are: Segmentation of brain tumors on MRI, deformable registration of
brain MRI volumes with tumors, and change quantification in temporal MRI series
of brain tumors.
The “Tumor-cut” method, developed for segmentation of brain tumors on MR
images, performed superior for some subsets of the multimodal tumor database and
comparable to the state-of-the-art techniques for the remainders. Local response
criteria, proposed by using the invariants of the Lagrange strain tensor, resulted
in measures more consistent with the clinical outcome than volumetric measure-
ments. The deformable registration method based on a novel approach, including
regularization using hyper-elastic mechanical models and tumor exclusion, resulted
in displacement fields consistent with the finite element simulations. Application
on real tumor case reveals the potential of our method to quantify healthy tissue
deformations due to the tumor mass effect.
Although, the results on solid tumors obtained by fully or semi-automatic meth-
ods are greatly improved recently with region based and machine learning ap-
proaches, improvement of the accuracy and robustness of multi-modal brain tumor
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segmentation methods, especially in the presence of the surgical cavity, remains as a
challenge for the field. A multi-modal “Tumor-cut” idea, where the transition rules
are devised using information from different MR intensities, could be developed for
a multi-label tumor segmentation. Segmentation of organs at risk (OAR) is still a
developing field, not only by more precise definition of the current OAR but also by
addition of new structure definitions using advanced imaging modalities (i.e. sub-
cortical regions by functional magnetic resonance imaging, fiber tracks by diffusion
MR imaging) and image analysis techniques (i.e. hippocampus segmentation using
shape priors [82]).
Improvement of the irradiation dose planning, to better cure the pathology and
protect the healthy tissue, is a major research area including advanced functional
imaging and mathematical modeling of the tumor evolution. Ongoing studies on
techniques, such as tumor growth modeling/simulation [67] or advanced imaging
modalities (i.e. Positron Emission Tomography, spectroscopy, diffusion MR imaging,
perfusion MR imaging) allow a better understanding of the tumor characteristics
hence the improvement of the irradiation margins.
Both, registration of the intra-patient longitudinal images and spatial normaliza-
tion in the presence of the tumor lesion are hot research topics due to both intensity
differences in lesion area and deformation of the healthy tissue caused by the mass
effect of the tumor. An open problem which might help to segment OAR automati-
cally and more accurately is deformable registration of the brains to the population
atlases in the presence of the tumor. This also allows better understanding and
categorization of the tumors by creating tumor probability atlases. Furthermore,
target tracking during therapy is another area in which methods including optical
tracking and registration of intra-therapy x-ray images are involved depending on
the radiotherapeutic hardware [83].
Better visualization and quantification of the local changes of the tumor evo-
lution is an open problem, which requires both understanding the clinical needs
and developing mathematical techniques to meet those requirements. Local tumor
response measures based on deformation tensor invariants, proposed in this thesis,
show promise for quantification of tumor response to therapy and relation to clinical
outcome, which should be further explored over larger data sets.
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Appendix A
Definitions and Conversions of Overlap Measures
Most commonly used measures to report segmentation overlap results in brain tumor
segmentation literature are Dice Overlap (D), Jaccard Index (J), False Positive and
Negative Volume Fraction (FPVF, FNVF) pairs. Dice Overlap (D) between two
label sets A and B is defined as:
D(A,B) = 2× s(A ∩B)
s(A) + s(B)
(A.0.1)
where s(A) denotes the cardinality of a set A. Jaccard Index (J) of two sets A and
B is defined as:
J(A,B) =
s(A ∩B)
s(A ∪B) (A.0.2)
and could be converted to Dice Overlap score by:
D(A,B) = 2× J(A,B)
1 + J(A,B)
(A.0.3)
False Positive Volume Fractions (FPVF) and False Negative Volume Fractions (FNVF)
of a segmentation (A) and a ground truth (M) are defined as:
FPV F (M,A) =
s(A−M)
s(M)
FNV F (M,A) =
s(M − A)
s(M)
(A.0.4)
and can be converted to Jaccard Index as:
J(M,A) =
1− FNV F (M,A)
1 + FPV F (M,A)
(A.0.5)
Similarly, Sensitivity and Specificity of a segmentation (A) and a ground truth (M)
are defined as:
Sensitivity(M,A) =
s(M ∩ A)
s(M)
Specificity(M,A) =
s(M { ∩ A{)
s(M {)
(A.0.6)
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Appendix B
Euler-Lagrange Condition of the Neo-Hookean Energy Function
The decoupled form of the neo-Hookean strain energy model is given as:
W =
µ
2
(
Tr(B)
J2/3
− 3) + 1
D1
(J − 1)2 (B.0.1)
where the deformation gradient tensor is Fij =
∂ui
∂xj
+ δij, B = FF
T and J is the
determinant of the deformation J = det(F ).
The derivation of the corresponding Euler-Lagrange condition requires the fol-
lowing term to be evaluated:
−
∑
j
∂
∂xj
∂W
∂Fij
(B.0.2)
Starting with the chain rule:
∂W
∂Fij
=
∂W
∂Tr(B)
∂Tr(B)
∂Fij
+
∂W
∂J
∂J
∂Fij
(B.0.3)
The trace of B can be written in terms of F as:
Tr(B) =
∑
i
Bii =
∑
i
∑
j
FijFij =
∑
i
∑
j
F 2ij (B.0.4)
The derivative ∂Tr(B)
∂Fij
’s can be calculated using Eq. B.0.4:
∂Tr(B)
∂Fij
= 2Fij (B.0.5)
The derivative ∂J
∂Fij
’s can be calculated using :
∂det(F )
∂Fij
= det(F )(F−1)ji (B.0.6)
The Euler-Lagrange term becomes:
−
∑
j
∂
∂xj
∂W
∂Fij
= −
∑
j
∂
∂xj
(
µ
J2/3
Fij − µ
3
Tr(B)
J2/3
(F−1)ji
+
2J(J − 1)
D1
(F−1)ji) (B.0.7)
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−
∑
j
∂
∂xj
∂W
∂Fij
= −µ
∑
j
∂
∂xj
J−2/3Fij +
µ
3
∑
j
∂
∂xj
Tr(B)J−2/3(F−1)ji
− 2
D1
∑
j
∂
∂xj
J(J − 1)(F−1)ji (B.0.8)
−
∑
j
∂
∂xj
∂W
∂Fij
= −µJ−2/3
∑
j
∂
∂xj
Fij − µ
∑
j
Fij
∂
∂xj
J−2/3
+
µ
3
Tr(B)J−2/3
∑
j
∂
∂xj
(F−1)ji +
µ
3
Tr(B)
∑
j
(F−1)ji
∂
∂xj
J−2/3
+
µ
3
J−2/3
∑
j
(F−1)ji
∂
∂xj
Tr(B)
− 2
D1
J(J − 1)
∑
j
∂
∂xj
(F−1)ji − 2
D1
∑
j
(F−1)ji)
∂
∂xj
J(J − 1) (B.0.9)
−
∑
j
∂
∂xj
∂W
∂Fij
= −µJ−2/3
∑
j
∂Fij
∂xj
+
2µ
3J5/3
∑
j
Fij
∂
∂xj
J
+
µ
3
Tr(B)J−2/3
∑
j
∂
∂xj
(F−1)ji − 2µ
9J5/3
Tr(B)
∑
j
(F−1)ji
∂
∂xj
J
+
µ
3
J−2/3
∑
j
(F−1)jiTr(
∂
∂xj
FF T )
− 2
D1
J(J − 1)
∑
j
∂
∂xj
(F−1)ji − 2(2J − 1)
D1
∑
j
(F−1)ji
∂
∂xj
J (B.0.10)
We utilize the following matrix derivatives:
∂
∂x
det(F ) = det(F )Tr[F−1
∂F
∂x
] (B.0.11)
∂
∂x
F−1 = −F−1∂F
∂x
F−1 (B.0.12)
Inserting Eq. B.0.11 into Eq. B.0.10, we get:
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−
∑
j
∂
∂xj
∂W
∂Fij
= − µ
J2/3
∑
j
∂Fij
∂xj
+
2µ
3J2/3
∑
j
FijTr(F
−1 ∂F
∂xj
)
+
µTr(B)
3J2/3
∑
j
∂
∂xj
(F−1)ji − 2µTr(B)
9J2/3
∑
j
(F−1)jiTr(F−1
∂F
∂xj
)
+
2µ
3J2/3
∑
j
(F−1)jiTr(
∂F
∂xj
F T )
−2J(J − 1)
D1
∑
j
∂
∂xj
(F−1)ji − 2J(2J − 1)
D1
∑
j
(F−1)jiTr(F−1
∂F
∂xj
) (B.0.13)
Inserting Eq. B.0.12 into Eq. B.0.13, we obtain the resulting update equation in
Eq. 5.23.
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Appendix C
Euler-Lagrange Condition of the Volumetric Term
The volumetric part of the strain energy can be given as:
Wvol =
K
2
(lnJ)2 (C.0.1)
where J is the determinant of the deformation F.
The corresponding term in Euler-Lagrange condition is derived as:
−
∑
j
∂
∂xj
∂W
∂Fij
= −
∑
j
∂
∂xj
∂
∂Fij
K
2
(lnJ)2
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
2
∑
j
∂
∂xj
2lnJ
J
∂J
∂Fij
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
2
∑
j
∂
∂xj
2lnJ
J
J(F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
∂
∂xj
lnJ(F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
((F−1)ji
∂lnJ
∂xj
+ lnJ
∂
∂xj
(F−1)ji)
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
(F−1)ji
1
J
∂J
∂xj
−KlnJ
∑
j
∂
∂xj
(F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
(F−1)ji
1
J
JTr[F−1
∂F
∂xj
] +KlnJ
∑
j
(F−1
∂F
∂xj
F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= −K
∑
j
(F−1)jiTr[F−1
∂F
∂xj
] +KlnJ
∑
j
(F−1
∂F
∂xj
F−1)ji
(C.0.2)
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Appendix D
Euler-Lagrange Condition of the Log Barrier
Log-barrier energy term is given as:
W = −λlnJ (D.0.1)
where J is the determinant of the deformation F.
The corresponding term in euler-lagrange condition is derived as:
−
∑
j
∂
∂xj
∂W
∂Fij
= −
∑
j
∂
∂xj
∂
∂Fij
(−λlnJ)
−
∑
j
∂
∂xj
∂W
∂Fij
= λ
∑
j
∂
∂xj
J−1
∂J
∂Fij
−
∑
j
∂
∂xj
∂W
∂Fij
= λ
∑
j
∂
∂xj
J−1J(F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= λ
∑
j
∂
∂xj
(F−1)ji
−
∑
j
∂
∂xj
∂W
∂Fij
= −λ
∑
j
(F−1
∂F
∂xj
F−1)ji
(D.0.2)
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